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INTRODUCTION 
The demand for beef has increased considerably in recent 
years and with this increased demand has come an increased 
commitment by producers to supply consumers with their needs. 
Consequently the feedlot system of preparing cattle for 
market has become an industry of enormous proportions and hence 
diseases, especially respiratory conditions, which thrive on 
the close confinement of large numbers of cattle, have become 
particularly significant to this industry. Virus diseases 
especially have contributed to a major erosion of the profit 
margin in the feedlot business and not the least important 
have been the diseases caused by herpesviruses. 
The number of herpesviruses associated with cattle has 
increased considerably, but a vaccine is available for only 
one of Lhesc (Herpesvirus bovis). There is some confusion as 
to the relationship of some of the more recently isolated 
bovine herpesviruses to the previously recognized strains. 
Strains of H. bovis have been associated with several different 
disease complexes, but the majority of workers have not been 
able to distinguish between the strains causing these syndromes. 
This has limited studies on the epidemiology, pathogenicity and 
pathogenesis of this virus. In addition H. bovis vaccine 
strains have been implicated in outbreaks of disease such as 
abortion in pregnant cows. The implication of such vaccine 
strains in disease outbreaks can in most eases only be 
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categorized as speculation, since no way exists to distinguish 
them from wild strains except possibly by very cumbersome 
pathogenicity trials. 
The object of this work was firstly to attempt to answer 
some of the questions raised above by developing procedures to 
differentiate in the laboratory between genital, respiratory, 
and vaccine strains of H. bovis, and secondly to study the 
serological interrelationship of some of the newer bovine 
herpesvirus isolates (DN599, FTCl, and Vll) and their relation­





In recent years the list of herpesviruses originating 
from cattle has enlarged considerably (12, 22, 117, 131, 140, 
142, 154, 176, 199, 249, 262, 270, 279). The relationship 
of several of these isolates with known bovine herpesviruses 
has not been adequately clarified (180, 249) and in addition 
members of some groups of antigenically homogeneous bovine 
herpesviruses differ in their pathogenicity for animals. 
In this review of the literature an attempt will be made 
to summarize the available information on bovine herpesviruses 
with emphasis on the interrelationship between the various 




The genital disease caused by H. bovis (213, 187) has 
been known in Europe for at least a century (60). The disease 
in cattle has been termed "vesicular venereal disease", 
"vesicular vaginitis", "coital exanthema", "coital vesicular 
exanthema", "exanthema pustulosum coitale", "Blaschenausschlag" 
and "infectious pustular vulvovaginitis" (120). Friedberger 
and Frohner (60) pointed out the prevalence of this disease 
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in Prussia, Germany and Bavaria during the second half of the 
nineteenth century. They also described the disease in cows 
and bulls and discussed the evidence which indicated that 
"Blaschenausschlag" was mainly a venereal disease but that 
nonvenereal transmission also occurred. 
Zwick and Gminder (303) in 1913 failed to pass the 
virus of "Blaschenausschlag" through bacterium-retaining 
filters but they were able to demonstrate the infectivity of 
vaginal exudate from affected cows. Reisinger and Reimann 
(210) in 1928 concluded that the agent of "Blaschenausschlag" 
was viral in nature after passing it through Reichl and Cham­
berlain Lg filters. The filterability of the "Blaschenaus­
schlag" virus was confirmed by Witte in 1933 (292). He also 
proposed the name "exanthema pustulosum coitale" to describe 
the disease since he found the basic microscopic lesion to be 
a pustule rather than a vesicle. 
In the U.S., Steddom (252a) in 1898 described an in­
fectious vaginitis and Parker (190) in 1900 described an 
infectious vulvar disease of cows which most probably were 
cases of infectious pustular vulvovaginitis (IFV). The "in­
fectious granular vaginitis" of cows described by Jones and 
Little (114) in 1927 probably was IPV in its convalescent 
stages (120). Gibbons (62) in 1944 reported that vesicular 
venereal disease had been present in New York state for at 
least 30 years. He was successful in transmitting the disease 
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to cows with infectious vaginal exudate. Gillespie et al. 
(66) detected antibodies to H. bovis in bovine serum col­
lected in 1948 in New Jersey, which constitutes serological 
proof that the virus has been present in the U.S. for some 
time. 
No significant developments in the knowledge of IPV 
transpired after the work of Reisinger and Reimann (210) and 
Witte (292) until Kendrick et c^. (120) in 1958 isolated the 
virus in bovine embryonic kidney cell cultures. Greig et al. 
(74) in the same year also reported isolating the agent of 
bovine coital exanthema in cell cultures. Kendrick et al. 
(120) coined the term "infectious pustular vulvovaginitis" 
for the genital disease associated with this virus. 
During the early 1950's an upper respiratory disease 
became evident among Colorado feedlot cattle (110, 174) and in 
California dairy cattle (164, 238). This disease was re­
stricted to cattle closely confined in large numbers. Mc-
Intyre (161) in 1954 transmitted the disease to cattle exposed 
by a variety of routes with an inoculum prepared from a pool 
of several tissues from infected amiTiSls. The transmissibil 
ity of the disease was confirmed by Chow et (37) and 
McKercher et al. (165) in 1955 in more defined experiments. 
The respiratory disease was first described as "necrotic 
tracheitis" by Miller (174) and later as "infectious rhino-
tracheitis" by Jensen et al. (110). In 1955 McKercher et al. 
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(165) proposed the name "infectious bovine rhinotracheitis" 
(IBR) for this disease, a term which has subsequently gained 
catholic usage. The terms "nasal catarrh" and "summer 
catarrh" have also been used for IBR in New Zealand (287). 
McKercher et a]^. (165) demonstrated the relationship of 
the California and Colorado isolates by cross-protection 
tests in cattle. The latter workers failed to pass the agent 
of IBR through a Seitz filter but maintained that the agent 
was viral in nature because of its resistance to anti­
biotics. In 1956 Madin et al. (142) isolated the IBR 
agent in cell cultures from nasal washings of experimentally 
infected cows. The latter authors concluded that the IBR 
agent was a virus because of its passage through bacterium-
retaining filters. 
Infectious bovine rhinotracheitis virus (IBRV) and in­
fectious pustular vulvovaginitis virus (IPW) were found by 
cross neutralization tests to be antigenically related by 
Gillespie et (65) in 1958. The latter concluded that IBR 
and IPV were different syndromes caused by the same virus. 
In addition iL has subsecjueiitly been repoxted that anti­
genically related viruses were associated with conjunctivitis 
(1, 206), infertility (149), encephalitis (59) and abortion 
(139) in cattle. The association of infertility and abortion 
with IPV has been suspected for over 60 years based on ob­
servations of natural outbreaks of the disease (291) . 
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Electron microscopic observation of IBRV was first 
achieved by Tousimis (276) in 1958 using an agar pseudo-
replica technique with partially purified virus. They also 
observed the development of IBRV in cell cultures by examining 
thin sections of infected cells. The inclusion of the IBR-IPV 
viruses in the herpesvirus group was suggested by Kubin and 
Klima (128) in 1960, Knocke and Liess (124) and Armstrong 
et al. (6) in 1961, and Schulze et a]^. (239) in 1964 on the 
basis of their experimental findings. The first attenuated 
vaccine against H. bovis was developed by Kendrick e_t al. 
(123). 
Ultrastructure 
Thin sections Several investigators have studied the 
intracellular morphology of various H. bovis strains, (6, 69, 
XU3, XUO, X^O , XJO, £41, ^/o) . xu UÛéSc 5 CUQico 
immature virions (nucleocapsids) were observed in the nucleus 
of infected cells (6, 69, 76, 108, 124, 133, 240, 244) appear­
ing as centrally or sometimes eccentrically located nucleoids 
(6, 76, 133) surrounded by a single membrane (6, 76, 133) 
probably the capsid (69). Nucleoids were often absent from 
nuclear virions (124). Mature enveloped virions were observed 
in the cytoplasm (6, 76, 124, 133) and extracellular spaces 
(6, 76, 124) . In two studies with IPW, several cytoplasmic 
virions appeared to consist of 2 or 3 nucleocapsids enclosed 
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in a common envelope (76, 240). A comparison of the size and 
morphology of H. bovis virions and virion subcomponents can 
be made from the data in Table 1. 
Negative staining Electron microscopy of negatively 
stained virions of IBRV revealed spherical nucleocapsids 
surrounded by loose envelopes (21, 42, 239, 285). In one study, 
nucleoids 35 nm in diameter were observed within capsids 
(239). The capsid core measured 82 nm (239) and 93 nm - 97 
nm (285) in two separate studies. The capsid had a hexagonal 
profile (42, 239, 285) and in 3 investigations measured 112 
nm (239), 102 nm - 114 nm (average 108.5 nm) (285), and 95 
nm - 99 nm (42) respectively. The capsomeres resemble hollow 
prisms and totalled 162 per virion (42, 239, 285). The 
capsomeres measured 12 nm x 10 nm (239) and 12 nm x 11.5 nm, 
(295) in 2 investigations,- while the axial hole diameter 
measured 3.5 nm (285). Five and 6 coordinated capsomeres were 
observed indicating a 5:3:2 icosahedral symmetry of the cap­
sid (239, 285). 
The diameter of the intact virion measured 165 nm - 230 
nm (average 190 nm) (239) and 200 nm (285) in 2 separate 
studies. An envelope consisting of a double-contoured mem­
brane with a thickness of 5 - 7 nm (285) or 7.5 nm (239), and 
with periodic projections radiating from it (42, 239) measuring 
8.5 nm in length (239) allowed virions to assume pleomorphic 
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Table 1. Size and morphology of virions and virion sub­
components of H. bovis strains in infected cells 
Structure Strain Size (nm) Shape Reference 
Nucleoid IPW 45 Spherical 76 
It 11 40-50 Spherical 240 
II II 35X55 Ellipsoidal 128 
II IBRV 55 Spherical 244 
II 11 50 Spherical 69 
II II 45 Spherical 6 
II II 
- Oval 133 
Nucleocapsid IPW 110 Spherical 76 
II II 60-100 Spherical 240 
11 II 100 Ellipsoidal 128 
II IBRV 110 Spherical 244 
II II 100 Spherical 69 
It II 115 Spherical 6 
II II 50X90 Oval 124 
II II 90-100 Spherical 105 
Virion IPW 100-170 Ellipsoidal 240 
11 II 150 Spherical 76 
:: IBRV 130-150 Spherical 105 
11 II 140-150 Spherical 244 
II II 158-180 Spherical 299 
II II 160-175 Spherical 69 
It II 140-155 Spherical 6 
Virion IBRV 120X80 Oval 133 
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shapes (42, 239, 285). 
Negatively stained preparations frequently contained naked 
capsids (42, 285) and in some instances empty capsids (42, 
239, 285). Differences were not detected between negatively 
i* stained IPW and IBRV virions in a detailed comparative study 
(239). 
Other Positively stained, partially purified, formal­
ized IBR virions (21) as well as IBR virions prepared by the 
agar pseudoreplica method (276) have also been examined by 
electron microscopy. Comparative data using these techniques, 
however, have not been published. 
Replication and growth characteristics 
Growth curve Logarithmic growth for intracellular 
IBRV occurred from 3-10 hours (259), 7-24 hours (29, 302), 
6-15 hours (106, 184), and 4-6 hours to 12 - 14 hours (18, 
244) post infection in various studies in cell cultures. 
Extracellular IBRV increased logarithmically between 7 and 18 
hours (259) , 8 and 24 hours (29), 10 and 36 hours (302), 6 
and 16 hours (18), and 16 and 32 hours (106) post infection in 
c e l l  c u l t u r e .  S y n t h e s i s  o f  I B R V  D N A  w a s  f i r s t  d e t e c t e d  2 - 4  
hours post infection in cell cultures, preceding infectious 
virus by 3 - 3.5 hours (184). An abortive infection with IBRV 
occurred in bovine kidney cells at 42C (255) . 
In a comparative study the growth curve pattern of an 
11 
intestinal strain of H. bovis differed from a brain isolate 
and several respiratory isolates (29). The extracellular 
virus concentration surpassed the intracellular concentration 
of the intestinal strain at a much earlier phase of the 
growth cycle compared to the other strains. The growth 
kinetics of IPW and a brain isolate was recently compared but 
no differences were detectable (18). In another investiga­
tion the growth of genital, respiratory, ocular and brain 
isolates were compared at 40C but no differences were 
evident (90). 
Cytological changes 
Cytopathic effect (CPE) Cells infected with H. 
bovis rounded up, shrank, became granular and clumped (6, 35, 
58, 120, 142). The development of spindle-shaped cells with 
elongated beaded processes (35) and multinucleated cells (6) 
after IBRV infection has been reported. In organ cultures 
IBRV infection results in the rounding of epithelial cells 
and cessation of ciliar motility (243). 
The CPE of several respiratory, genital, ocular and brain 
isolates have been compared (90) but the type of CPE could not 
be correlated with the site of isolation of the viruses. In 
the latter study 3 types of CPE were observed in infected cells 
namely globular syncytia, flat syncytia, and a stranded 
fibroblastic development of the cells. In another study no 
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qualitative or chronological differences in CPE were detected 
in IPW- and IBRV-infected cells (171) . 
Inclusions Amphophilic to eosinophilic Cowdry 
type A intranuclear inclusions typical of herpesviruses, 
occurred in H. bovis-infected cells (6, 35, 106, 188, 256). 
The demonstration of inclusions in H. bovis-infected cells 
was dependent on specimen preparation since unfixed prepara­
tions did not contain any (6, 76, 235) . The type of fixation 
procedure was found to determine the presence or absence 
of intranuclear inclusions (235, 256) . The metabolic 
inhibitors bromodeoxyuridine (BUDR) (258) , fluorodeoxyuridine 
(FUDR) (258) , and iododeoxyuridine (lUDR) (135) did not pre­
vent the formation of inclusions in IBRV-infected cells but 
hydroxyurea (104) did. 
In one study a H. bovis-strain from calves with encepha­
litis did not produce intranuclear inclusions in infected 
cells (58). In another study intranuclear inclusions were 
observed in infected cells with only 2 of 6 H. bovis strains 
tested (272) . 
Viral antigens The fluorescent antibody test (FAT) 
revealed that H. bovis antigens first appeared perinuclearly 
and then gradually spread throughout the cytoplasm without in­
volving the nucleus of infected cells (13, 55, 57, 69, 135, 
272). In some instances nuclear fluorescence occurred late in 
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the infectious cycle (17, 106, 302) but this could have been 
due to superimposition of cytoplasmic fluorescence (57, 69). 
The accumulation of fluorescent antibody-stainable H. bovis 
antigens in infected cells was not inhibited by hydroxyurea 
(104), lUDR (135, 272), FUDR (272), arabinofuranosylcytosine 
(272) but actinomycin D and puromycin did inhibit the 
synthesis of these antigens (272). Conjugates prepared from 
sera of rabbits inoculated with IBRV, nonionic detergent-
degraded IBRV, ether-treated IBRV and boiled debris of IBRV-
infected cells all resulted in similar fluorescence in IBRV-
infected cells indicating that all these conjugates were 
probably staining the same antigen (272). 
In one study an intestinal strain of H. bovis produced 
fluorescence in cells within 90 minutes post infection while 
uCxiCJ. xii V CO Cxy a CwjL o ouocxvcru -Liiu. u J_ci j_ a. c. -a Aiv-'CiJL.j 
(272), 5 hours (17, 135) and 6 hours (57, 106, 302) post in­
fection using various other H. bovis isolates. The FAT ap­
plied to IBRV- and IPW-infected cells resulted in similar 
fluorescence (13, 17). In another study similar results were 
observed with the FAT in cells infected with 6 different 
strains of H. bovis (272). In a recent study employing the 
FAT, IBRV, Marek's disease virus (MDV), and the Epstein-Barr 
virus (EBV) were found to share antigen(s) (55). 
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Histochemistry Green fluorescence in cells infected 
with H. bovis strains and stained with acridine orange occurred 
only along the periphery of nuclei (6, 106, 258, 302). Viral 
DNA synthesis became detectable by means of the acridine 
orange technique only after 6 hours post infection in IBRV-
infected cells (302). 
In one study feulgen staining also failed to demonstrate 
DNA in intranuclear inclusions of IBRV-infected cells (188) . 
German investigators, however, succeeded in staining IBRV-
induced inclusions in cells (133, 235) but the type of fixa­
tive used was found to influence the results (235) which could 
account for false negative results. The IBRV-induced in­
clusions in cells were not stained using the PAS, sudan III 
and Brachet procedures (235). 
Plaque formation Herpesvirus bovis strains formed 
plaques in cell monolayers maintained under agar-containing 
medium (77, 219, 227, 259), or liquid medium containing 
specific antiserum (258). Less distinct plaques developed 
using Postlev/aite ' s liquid overlay method (219). A linear 
relationship between H. bovis concentration and plaque count 
has been demonstrated (77, 259). Infective center assay 
set the plating efficiency of IBRV at 0.7 - 0.83 (227). 
An intestinal strain of H. bovis produced plaques in cell 
culture that were similar in size to those produced by several 
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IBRV strains and a brain isolate (29). In another investiga­
tion both IBRV and IPW produced large and small plaques in 
bovine calf kidney cells (171). 
Ultrastructural development Entry of IBRV into cells 
has been observed to occur by fusion of the viral envelope 
with the cell membrane (300) but in another study IBRV 
virions were observed in numerous pinocytotic vesicles within 
the cytoplasm of infected cells (243). Virus-like particles 
were observed within the nucleus of IBRV-infected (6, 69, 76, 
108, 124, 133, 194, 195, 244, 299) and IPW-infected cells 
(76, 128, 240) before they appeared in the cytoplasm. 
Nuclear virus particles in H. bovis-infected cells con­
sisted exclusively of full and empty capsids indicating that 
nucleoid development occurred within the preformed capsid 
(108, 244). In most cases the nucleocapsids were scattered 
within the nucleus of infected cells (5, 69, 244) but 
crystalline intranuclear aggregates were observed with some 
strains (69, 124, 133). Progeny nucleocapsids were observed 
within the nucleus of H. bovis-infected cells at 3 - 5.5 hours 
(244, 299),- 8 hours (105), and 18 hours (133) post infection. 
Virions matured by budding through the inner lamella of 
the nuclear membrane (69, 105, 108, 240, 244, 299). Budding 
has also been observed in the cytoplasm through endoplasmic 
reticulum membranes (105, 240, 299) and one investigator found 
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the latter to be the most important method of maturation 
(194, 195). Viral egress from the perinuclear cisternae in H. 
bovis-infected cells apparently occurred via a modified endo­
plasmic reticulum (69, 107, 108, 240, 244, 299) which per­
mits release of virus without lysis of the cells (240, 299). 
Viral egress via reverse phagocytosis was suspected by some 
workers (107, 244) especially late in the infectious cycle 
(244) since virions were frequently observed within vacuoles 
in the cytoplasm of infected cells. 
Most of the ultrastructural work was carried out with 
IBRV with the exception of 3 studies (69, 76, 240). Only one 
comparative investigation has been reported (76). In the 
latter instance the ultrastructural development of IBRV and 
IPW were found to be similar. In addition the intracellular 
development and morphology of a H. bovis intestinal strain was 
similar to IBRV (69) . One strain of IPW was associated with 
filamentous intranuclear structures and intracytoplasmic in­
clusions consisting of densely packed nucleocapsids embedded 
in an electron dense matrix in infected cells (240). In one 
instance cells infected with IBRV contained intracytoplasmic 
membranous profiles enveloping dense osmophilic material (168) 
while another IBRV strain was associated with intracytoplasmic 
lipid bodies in infected cells (244). 
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Viral inhibition 
Chemical Herpesvirus bovis replication in cell 
cultures was inhibited by lUDR (135, 226, 272), FUDR (258, 
272), BUDR (226, 258), bromodeoxycytidine (226), actinomycin 
D (272), puromycin (226, 272), hydroxyurea (104), mitomycin 
(226), cytosine arabinoside (226), rifampicin (251), isatin 
thiosemicarbazone (184), methyl thiomethylcarbazone (184) and 
aminopterin (226) . Replication of IBRV was not affected by 
arabinofuranosylcytosine (272). Replication of IBRV in cells 
treated with BUDR and FUDR resulted in progeny dependent on 
these drugs for replication (257). 
Interferon Circulating interferon was induced 
in cattle with IBRV which proved to be susceptible to this 
interferon (214) . Avirulent IBRV induced high levels of local 
interferon after intranasal inoculation in cattle (274). 
Virulent IBRV inoculated intranasally also induced high 
levels of local interferon and IPW induced local interferon 
after intragenital inoculation (3). Interferon was also 
induced in bovine embryonic kidney and chicken embryo fibro­
blast cell cultures by IBRV, but the virus was not susceptible 
to this interferon (277) . 
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Physical and chemical properties 
Filtration studies Herpesvirus bovis strains were 
passed through Reichl filters (210) , Chamberlain L3 filters 
(210) , gradocol membranes with an average pore diameter (apd) 
of 590 nm (287), fine sintered glass filters (142) , plastic 
membrane filters with an apd of 300 nm - 400 nm (58, 128), 
and Selas 03 filters (120). The virus was retained by Seitz 
EK filters (120, 128, 165), plastic membranes with an apd of 
250 nm (58) and gradocol membranes with an apd of 150 nm 
(287) . 
A conjunctival isolate of H. bovis was passed through 
millipore filters with an apd of 100 nm (273) . The diameter 
of a brain isolate of H. bovis virions was calculated to be 
175 nm by applying filtration data with plastic membranes to 
Black's formula (58). 
Hemagglutination and Hemadsorption Various strains of 
H. bovis were unable to hemagglutinate erythrocytes from 
several animal species under various conditions of tempera­
ture and pH (58, 290). Hemadsorption by cells infected with 
a conjunctival isolate (273) or a skin isolate (31) was not 
observed at various temperatures with guinea pig (31, 273) or 
human type 0 (273) erythrocytes. 
19 
Chemical sensitivity Herpesvirus bovis strains were 
sensitive to ether (6, 31, 75, 78, 178, 218), chloroform (31, 
78, 178), formalin (264), calcium alginate (51), acetone 
(75), alcohol (75), sodium desoxycholate (78), formol (264), 
caustic soda (264), chlorine-containing compounds (264), 
phenol derivatives (264), quaternary ammonium compounds 
(264) , mercury-containing compounds (264) , and iodine-contain­
ing compounds (264). Ether-inactivated IBRV was reactivated 
using facilitators (talc, calcium phosphate dihydrate and 
chromic oxide) which adsorbed virions and attached them to 
viable cells (218) . 
Stability The temperature stability of various 
strains of H. bovis is summarized in Table 2. In one trial 
an intestinal strain of K. bovis was slightly more heat sensi­
tive than a brain isolate and 2 respiratory isolates (29). 
pH stability At 4C IBRV was stable for at least 
60 days at pH 6.0 - pH 9.0 (75). The stability of IPW at 4C 
ranged from a pH of 5.0 to a pH of 9.0 (78). 
Freezing Three (6) to 5 (259) cycles of freezing 
and thawing did not affect the titer of IBRV. 
Lyophilization Lyophilization was found to be a 
suitable method of preserving IBRV (75, 128). 
Table 2. Temperatuie stability of H. bovis strains 
Temperature Strain Period of viability Reference 
-70C IPW At least 6 months 78 
-70C Brain No titer lost in 7 months 58 
-60C IBRV At least 3 months 6 
-20C IPW At least 2 months 78 
-20C Brain IO^TCID Q^ lost in 7 months 58 
4- 5C IPW 15 days 78 
U
 
un 1 IBRV 60 days at least 75 
4- 5C Brain IO^TCID Q^ lost in 2 months 58 
20C IPW 6 days 78 
22C IBRV 50 days 75 
37C IBRV 16-hour half life 227 
37C IBRV 10-hour half life 259 
37C IBRV 24 hours 78 
37C IBRV 10 cays 75 
37C Intestinal 42% survival in 24 hours 29 
Table 2 (Continued) 













55% survival in 24 hours 
4.5-hour half life 
3.5-hour half life 
10 minutes 
21 minutes 








Nucleic acid Since BUDR, lUDR and cytosine arabino-
side inhibited IBRV replication, it was concluded that the 
genome of this virus consisted of DNA (225). Some data have 
been published describing DNA extracted from partially 
purified H. bovis virions. These data are summarized in 
Table 3. 
Electrophoresis Carrier-free zone electrophoresis in 
a glucose density gradient was used to differentiate between 
IBRV and IPW even though these 2 viruses were serologically 
identical (266) . Freshly isolated strains of H. bovis of 
genital and respiratory origin were differentiated in this 
manner, but after several passages in cell cultures consider­
able changes of virion surface charges occurred so that 
Table 3. Characteristics of H. bovis DNA 


























^Grams per cc. 
^Guanine plus cytosine, moles per cent. 
""SedimenL^tion coefficient. 
^Molecular weight in daltons. 
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differences were less evident (155) . The original charges 
of the cell-adapted strains were restored after passage 
through cattle (155). Two European IBRV strains were in­
distinguishable by zone electrophoresis (183) . 
Centrifugation The sedimentation coefficient of IPW 
virions was found to be similar to that of IBRV virions (266) . 
Pathogenicity 
Host range 
Cell cultures The susceptibility of various 
cell cultures to H. bovis strains is summarized in Table 4. 
Various H. bovis strains were compared by their growth in 
pig kidney cell cultures (90). In this study, 1 of 3 
respiratory strains, 1 of 6 genital strains, one brain isolate 
and one ocular isolete to produce cytopathic effects. 
In 2 studies the susceptibility of various cell cultures to 
IBRV was identical to their susceptibility to IPW (169, 171). 
A brain isolate grew better in bovine thymus cell cultures 
than in bovine kidney, bovine pancreas, and bovine thyroid 
cells (58). 
Animals Various disease syndromes are associated 
with H. bovis infection in cattle (58, 120, 142, 149, 165, 
206). Outbreaks of respiratory disease in goats (179) and 
balanitis and vaginitis in swine (231) were associated with 
24 
Table 4. The susceptibility of various cell cultures to H. 
bovis strains 
Virus strain Cell culture Cytopathic 
effect 
Reference 












L cells (line) 
Bovine lymph node 
(normal) 
Bovine lymph node 
(lymphadenomatosis) 
Dog kidney 
Dog kidney (line) 
Lamb kidney (line) 
Rabbit kidney (line) 
Pig kidney (line) 

































Table 4 (Continued) 
Virus strain Cell culture Cytopathic Reference 
effect 
IBRV HeLa (line) 32 
SIRC (rabbit line) + 50 
Bovine skin + 32 
Bovine muscle + 32 
Rhesus monkey kidney 217 
Cynomolgus monkey 
kidney 217 
Human amnion + 276 
Bovine nasal organ 
culture + 243 
Bovine tracheal 
organ culture + 243 
Bovine vaginal 
organ culture + 243 
Lamb tracheal organ 
culture + 243 
Sheep kidney + 287 
Pig kidney + 90, 287 
Horse kidney + 287 
Rabbit spleen + 6 
Green monkey kidney - 90 
BHK (line) + 171 
^Adapted strain. 
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Table 4 (Continued) 
Virus strain Cell culture Cytopathic Reference 
effect 
IPW Bovine kidney + 120, 
II Bovine lymph node 
(normal) + 169 
11 Bovine lymph node 
(lymphadenomatosi s) + 169 
II Bovine lung + 169 
II Dog kidney (line) - 169 
II Lamb kidney (line) + 169 
II Rabbit kidney (line) + 169 
II Pig kidney (line) + 169 
II Horse kidney (line) + 169 
tl Pig kidney + 90 
II Green monkey kidney - 90 
M Cog kidney - 90 
It BHK (line) + 171 
Strain Bovine thymus + 58 
II Bovine adrenal + 58 
II Monkey kidney - 58 
II Bovine kidney + 58 
II Bovine pancreas + 58 
II Bovine thyroid + 58 
II Pig kidney - 90 
II Dog kidney - 90 
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Table 4 (Continued) 
Virus strain Cell culture Cytopathic Reference 
effect 
CNS strain Green monkey kidney - 90 
Ocular strain Pig kidney - 90 
" Dog kidney - 90 
' Green monkey kidney - 90 
viruses antigenically related to H. bovis. Respiratory 
disease was elicited in goats after intranasal and intra­
venous inoculation with IBRV (168), but in another study goats 
were refractory to IBRV (280). Nervous symptoms occurred in 
swine inoculated intracerebrally (187) with IBRV, but sub­
clinical infection resulted from intravenous (168, 187, 293), 
intranasal (168, 187, 293), subcutaneous (293) and intra­
tracheal (293) inoculation. Subclinical infection occurred 
in sheep and horses inoculated intravenously and intra-
nasally with IBRV (168), but ewes (146, 16) and mares (146) 
were refractory to IPW. In one experiment mares and 
stallions developed leukopenia after genital exposure to IPW 
(25). Mule deer inoculated intranasally with IBRV developed 
respiratory disease (36) . Dogs were refractory to intra­
peritoneal and intracerebral inoculation of a brain isolate 
of H. bovis (58), and the eland was refractory to a strain of 
IPW (147). 
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Serological evidence of H. bovis infection was detected 
in the sera of swine (2, 187), water buffalo (261), mule deer 
(36), hippopotami (118), African buffalo (118, 222), and 
wildebeest (222) . Antibodies to H. bovis in dog, horse and 
human sera were detected in Iran using the immunodiffusion 
test (2). 
Laboratory hosts Rabbits (16, 37, 58), adult 
mice (9, 37, 58), suckling mice (6, 9, 16, 37, 58), embryonated 
hen's eggs (6, 16, 37, 58), guinea pigs (9) and day-old 
chickens were refractory to several H. bovis strains inocu­
lated by a variety of routes. However, one strain of IPW 
produced conjunctivitis in rabbits inoculated into the eye 
(16). In another study (6) orchitis and epidermal erythema 
developed in rabbits after intratesticular and intradermal 
inoculation respectively with IBRV. In the latter study 
high concentrations of virus were necessary and the virus 
could not be passaged in rabbits. 
Diseases in cattle 
Respiratory isolates (IBRV) Respiratory disease 
associated with IBRV is restricted to the upper respiratory 
tract (110, 164, 165). Occasional conjunctivitis (110, 164, 
165), enteritis (15) and abortion (110) were observed in IBR 
outbreaks. la a few outbreaks of respiratory disease due to 
the virus, conjunctivitis was a prominent symptom (44, 268). 
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Two instances of concurrent genital and respiratory disease 
due to H. bovis have been reported but the 2 syndromes were 
not observed together in any one animal (38, 115). Abortion 
also occurred in one of these latter outbreaks (115). 
Upper respiratory disease was elicited in cattle with 
IBRV after intranasal (37, 142, 165), intravenous (165) and 
intramuscular inoculation (165). Occasionally diarrhea (37) 
and conjunctivitis (165) was observed in experimentally in­
fected cattle. 
Intravaginal inoculation of IBRV in cows resulted in 
typical IPV symptoms (65, 90, 134, 169, 171, 268). Udder in­
fusion with IBRV resulted in mastitis in cows (73), and oral and 
nasal inoculation of gnotobiotic calves elicited an asympto­
matic meningoencephalitis (52). A septicemic, frequently 
fatal disease occurred in newborn calvcs infected intrave­
nously with IBRV (8). One strain of IBRV was avirulent for 
cattle inoculated intramuscularly, but nasal inoculation did 
elicit typical xespiratory symptoms (55). 
Genital isolates (IPW) In Europe IPV in cows has 
been known for over a century without any apparent association 
with respiratory disease (162). Outbreaks of pustular vulvo­
vaginitis in cows (120, 126) and ulcerative balanoposthitis 
(25, 92) or pustular balanoposthitis in bulls (88) was 
associated wii-h IPW. Some IPW strains were associated with 
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anterior vaginitis in cows (149), and orchitis (149), epididy­
mitis (149), poor semen quality (24, 149) and impotence (25, 
149) in bulls. Infertility and endometritis occurred in cows 
inseminated with IPVV-contaminated semen (121). However, in 
other outbreaks semen quality remained unchanged (88, 92), 
impotence in bulls was not observed (88, 92), infertility in 
cows and bulls was not evident (126) and abortions were not 
encountered (126, 269). Asymptomatic infection in bulls was 
also encountered (92, 127, 230). In most outbreaks of IPV, 
respiratory and ocular symptoms were not evident (162) . How­
ever, on some occasions conjunctivitis (100, 126), respira­
tory signs (38, 115) and abortions (115) occurred con­
currently with IPV. 
Genital exposure of susceptible cattle to IPW resulted 
in typical vulvovaginitis (120. 250) and balanoposLui Lis 
(250, 267), but respiratory and ocular involvement did not 
develop (120, 250, 267). 
Orchitis in bulls resulted after intrapreputial (25, 125), 
intraurethral (149), and intratesticular (125, 156) inocu­
lation of IPW. Some investigators however, failed to produce 
orchitis in bulls using intrapreputial inoculation of IPW 
(40, 267). Abortion did not occur after intravaginal inocula­
tion of pregnant cows (120, 250) but did occur after direct 
inoculation into fetuses (263). 
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Reduced fertility in cows (149) and sperm quality de­
terioration in bulls (25, 125, 149) occurred after experimental 
infection with some IPW isolates. An endometritis ensued in 
cows after intrauterine insemination of IPW (120, 121) which 
prevented the establishment of pregnancy (121). Other IPW 
strains did not affect fertility in cows (39, 120) or the 
semen quality of bulls (40, 88) after experimental inocula­
tion. In one study impotence resulted in bulls experimentally 
infected with IPW (25) , but this was not observed in another 
study (92). A transient epididymitis developed in bulls after 
urethral inoculation with an IPW strain (149) and mastitis 
occurred in cows after udder infusion with IPW (73) . 
Intranasal inoculation of susceptible cattle with several 
IPW strains failed to produce any symptoms except for pyrexia 
(65, 145, 148, 169) . A South African IPW isolate, peculiar 
in that it produced an anterior nonpustular vaginitis, failed 
to elicit even a temperature response in susceptible cattle 
inoculated intranasally (148, 149). The temperature reaction 
in susceptible cattle was greater after intravaginal inocula­
tion than after intranasal inoculation with IPW (169) . In 
addition the pyrexia resulting from IPW infection in cattle 
developed later and failed to reach the same peaks as it did 
after IBRV infection using either respiratory or genital 
routes of inoculation (169). 
However, in some investigations IPW did produce respira-
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tory symptoms after intranasal inoculation (90, 171, 250, 
267, 269) and conjunctivitis after ocular exposure (250, 
267). One IPW strain failed to cause encephalitis in intra-
cerebrally inoculated calves but did result in typical 
vaginitis and mild rhinitis in cows after intravenous inocu­
lation (250) . 
Fetal isolates Herpesvirus bovis has frequently 
been isolated from aborted fetuses and their associated mem­
branes (139, 170, 228). Abortions were also recorded in preg­
nant cows after vaccination with live IBRV vaccine (160, 170, 
228). Frequently H. bovis abortions in cows occurred without 
a history of any other illness in the herd (17 0, 228), but 
abortions soon after an outbreak of IBR or after cases of 
conjunctivitis in a herd have been recorded (228). 
Expei iinfcjiiLai liioculaLj-Oii of caLLle wxtli various fetal 
isolates of H. bovis has produced abortion (122, 139, 17 0, 
229), upper respiratory disease (139, 170, 229), conjunctivitis 
(139, 170, 229) and vulvovaginitis (139) . Nervous signs were 
not elicited in calves with a fetal isolate inoculated intra-
cerebrally or intravenously (163) . 
Ocular isolates Outbreaks of conjunctivitis (1, 46, 
206, 268, 273) and keratoconjunctivitis (93, 260) in cattle 
were associated with H. bovis. The keratitis appeared to be 
secondary to conjunctivitis (93) . In many of these outbreaks 
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of ocular disease in cattle, respiratory or genital symptoms 
were not observed (1, 206, 273). In some instances however, 
conjunctivitis due to H. bovis was associated with respira­
tory disease (46, 93, 260, 268). 
Ocular strains of H. bovis inoculated into the eyes of 
calves produced conjunctivitis (1, 93, 178) and keratitis in 
some instances (93) . In some studies respiratory disease did 
not develop in calves inoculated with ocular strains of H. 
bovis (1, 178) , but respiratory involvement was observed in 
other studies with ocular strains (46, 93). Intravaginal in­
oculation with an ocular H. bovis strain elicited vaginitis in 
cows (46). 
Brain isolates Encephalitis in calves has been 
associated with H. bovis infection (9, 11, 58, 112). Most of 
these outbreaks were notable since other symptoms commurily 
associated with H. bovis infection in cattle were absent 
(9, 58, 112). 
Brain isolates of H. bovis produced encephalitis, often 
fatal, in cattle inoculated by the intracerebral (80, 111, 
265), intranasal (7, 59, 80), and epidural (7) routes but not 
via the intravenous (7, 9, 111), intraperitoneal (9), oral 
(9, 80), subcutaneous (80), intramuscular (11) or ocular (9) 
routes. Several brain isolates failed to elicit respiratory 
disease in calves (9, 59) but conjunctivitis (9, 59) and 
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vaginitis (59, 80) were observed after appropriate inoculation. 
One H. bovis isolate, originating from a calf with encephalitis, 
produced mild respiratory symptoms but not encephalitis in 
intranasally infected calves (11). 
Other isolates Herpesvirus bovis was isolated from 
the intestinal tract of a calf with enteritis (71). This iso­
late produced mild to moderate respiratory symptoms in intra­
nasally inoculated calves (71). Calves infected orally or 
intravenously with the latter isolate developed Ins ions in 
the gastro-intestinal tract and associated lymph nodes and in 
the adrenals of some calves (71). 
In 2 investigations H. bovis was associated with ocular 
tumors in cattle (53, 271). In one instance H. bovis was 
associated with recurrent perineal dermatitis (31). 
Serology and immunity 
Serological techniques Immunity and serological 
studies with H. bovis have been conducted by cross-protection 
tests in cattle (166), serum neutralization of viral cyto-
pathogenicity (142, 167, 177), serum-virus ncutralizat ion 
kinetics (91), plaque reduction by serum (171"., 219), incaunodif-
fusion (2, 33, 54, 55, 171), passive heinacjglutinatioi; '242 , 
281, 290), Immunoelectrophoresis (55), comp] e'l.ent fixation 
(33, 202), indirect fluorescent antibody test (13, 55), micro-
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titer serum neutralization (216) and a serum neutralization 
procedure based on the color reaction in the medium of in­
fected cells (72) . 
Relationship of H. bovis to other viruses Antigenic 
relationship between H. bovis and H. hominis (202), B-virus 
(202), H. suis (202) , and equine rhinopneumonitis was demon­
strated using the complement-fixation procedure. These re­
lationships were not detectable when reciprocal neutralization 
tests were done (33, 202). The sharing of antigens between K. 
bovis and equine rhinopneumonitis was confirmed by immuno­
diffusion (33) . 
A one way relationship between 2 bovine enteroviruses and 
H. bovis in cross-neutralization tests was reported (182) . 
In a recent study it was reported that H. bovis shared several 
antigens with Marek's disease virus and at least one antigen 
with Epstein-Barr virus (55) . In the latter investigation the 
indirect fluorescent antibody, immunoelectrophoresis, and 
immunodiffusion tests were employed. 
Interrelationship of H. bovis strains Herpesvirus 
bovis strains originating from a variety of disease syndromes 
were antigenically homogeneous when tested by reciprocal 
neutralization (1, 9, 31, 59, 65, 120, 139, 149, 169, 171, 178, 
282). However, an intestinal isolate was related reciprocally 
to a brain isolate but nonreciprocally to a respiratory 
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isolate (70). 
Genetron-extracted antigens of IBRV and IPW were 
indistinguishable by immunodiffusion (171). Rabbit sera were 
unsuitable for comparative purposes in this test because of 
nonspecific reactions. 
Infectious pustular vulvovaginitis and IBRV were in­
distinguishable by reciprocal plaque reduction using both 
the alpha and beta procedures (172). Both these viruses 
produced large and small plaques and cloned populations of 
these variants were neutralized equally well by antiserum 
to mixed and to large plaque variants (172) . 
In one study 2 genital and 2 respiratory H. bovis 
strains were neutralized by rabbit sera at an equal rate at 
37C (26) . Statistical analysis of neutralization slopes and 
comparison of normalized neutralization rate constants led to 
the conclusion that an IBRV strain, a vaccine strain and one 
brain isolate were antigenically similar but differed sig­
nificantly from an intestinal isolate (29) . In a recent study 
statistical analysis of normalized rate constants was employed 
to compare 2 IPW and 2 IBRV iboldtea (90) . In the laLLer 
study the 2 IBRV strains and one IPW strain were closely re­
lated but differed significantly from the second IPW strain. 
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Allerton Group of Viruses 
History 
Allerton virus was isolated in 1957 in cell cultures from 
cases of suspected lumpy skin disease of cattle in South Africa 
by Alexander et (4). This virus produced pyrexia, local­
ized lymphadenitis, and generalized skin nodules in cattle 
inoculated subcutaneously with the virus (4). 
A small epizootic of udder lesions in cows due to an 
Allerton-type virus in Ruanda Urundi in Central Africa was re­
ported in 1960 by Huygelen ^  al. (98). In this outbreak 
lesions were also found on other parts of the body and on the 
buccal mucosa of infected animals. This Central African iso­
late appeared more virulent than the South African strain 
(98) . 
In 1964 a virus was isolated in Scotland from an ulcera­
ting condition of cows teats by Martin et al^. (154) . The virus 
was also isolated in 1969 from stored material collected from 
a gangrenous bovine udder in 1958 (49) . The name "bovine mam-
millitis virus" (BMV) was proposed for this isolate by Martin 
et al. in 1965 (153). Martin et reported the antigenic 
relationship between BMV and Allerton virus in 1966 (153) . 
The presence of a virus antigenically related to Allerton 
virus in skin lesions of Minnesota cattle was reported by 
Yedloutschnig et al. (294) in 1970. A similar virus has since 
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also been isolated from teat and udder lesions in cows in New 
York State (286). 
Electron microscopic examination of BMV in 1966 (150) and 
Allerton virus in 1967 (204) revealed the morphological 
affinity of these viruses to the herpesvirus group. 
Ultrastructure 
Thin sections The morphology of virions within cells 
infected with viruses of the Allerton group was similar to 
that of herpesviruses (27, 150, 248). Immature virions 
(nucleocapsids) were observed in the nucleus of infected cells 
(27, 130, 150, 248, 294). The nucleocapsid consisted of a 
spherical membrane, probably the capsid, with or without a 
centrally located nucleoid (130, 152, 248). In one study, free 
nucleoids were observed in the nucleus of infected cells in 
tbe emarginated chromâtin-like material (248). Crystalline 
viral arrays located in the central portion of the nucleus of 
BMV-infected cells were observed in one study (152) . Mature 
enveloped virus occurred extracellularly and within the cyto­
plasm of infected cells (27, 150, 152, 248, 294). 
The intracellular morphology of Allerton virus, BMV and 
the Minnesota isolate were indistinguishable (27) . In one 
study, bizarre, abnormal virions enclosed in an osmophilic 
membrane were observed extracellularly and within the cyto­
plasm of BMV-infected cells (248). In another study with BMV, 
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cytoplasmic clusters of virions embedded in electron-dense 
material were noted in infected cells (152) . Electron-
dense material occurred between the capsid and envelope of some 
BMV virions (248). Virion and virion subcomponent sizes of 
several BMV strains are listed in Table 5. 
Table 5. Sizes of intracellular virions and subvirion 
components of BMV 
Structure Size (nm) Reference 
Nucleoid 35-40 248 
Nucleocapsid 100 152 
II 80-90 248 
tl 75-80 130 
Virion 120 -150 248 
II 160 152 
Negative staining Electron microscopy of negatively 
stained virions of BMV (64, 150), Allerton virus (204), and an 
oral isolate of this virus group (34) revealed typical herpes­
virus particles. Four basic morphological types, namely full 
enveloped particles, full naked capsids, empty enveloped 
particles, and empty naked capsids, were observed in nega­
tively stained preparations of BMV (64). Nucleocapsids were 
frequently hexagonal In outline (64) , possessed icosahedral 
symmetry (204), and their capsomeres resembled hollow cylinders 
(34, 64, 150) with a polygonal cross section (64). The sizes 
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of virions and subvirion components of the Allerton group of 
viruses are listed in Table 6. 
Table 6. Sizes of negatively-stained virions and subvirion 






































Replication and growth characteristics 
Growth curve The logarithmic growth of intracellular 
BMV occurred between 24 and 56 - 72 hours post infection in 
one study (223) and 8 and 18 - 32 hours post infection in 
another study (253) . Intracellular viral replication preceded 
extracellular virus by 8 hours (223) and 2-4 hours (253). 
The intracellular logarithmic phase of replication of an oral 
isolate lasted from 12 to 144 hours post infection (34). 
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Cytoloqical changes All members of the Allerton virus 
group examined produced ballooned, multinucleated, giant cells 
in cell cultures (4, 34, 47, 96, 154, 223, 294). The giant 
cells developed either as multinucleate stellate bands or as 
globose syncytia (223) and some contained several hundred 
nuclei (96, 223). Syncytium development in cells was first 
observed 10 - 16 hours after infection with BMV (96, 223). 
Typical type A intranuclear inclusions were observed in 
the giant cells of cell cultures infected with Allerton virus 
(96), BMV (154), New York isolate (286) and an oral isolate 
(34) . 
Plaque formation Plaque development by BMV (253) 
and an oral isolate of the Allerton virus group (34) in cell 
monolayers was reported. A linear relationship between virus 
concentration and plaque number was demonstrated (253). 
Titers of approximately 10^ plaque-forming units (pfu) 
per ml were obtained with BMV in cell cultures under agar and 
carboxymethylcellulose overlays (253). Titers of approxi­
mately 10^ pfu per ml were obtained with an oral isolate in 
cells under agar (34). The BMV plaques developed to 3 - 4 mm 
within 48 hours (253) , while the oral isolate plaques were 
1 - 3 mm after 3 days (34). 
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Ultrastructural development Nucleocapsids formed in 
the nucleus of BMV-infected cells (130, 150, 152, 248, 294) 
before mature virions were observed (130). Free nucleoids, 
crystalline arrays of nucleocapsids (152) , fibrillar deposits 
(152), and empty capsids (248) were also detected in the 
nuclei of BMV-infected cells. 
Virion maturation occurred by budding through the nuclear 
membrane (152, 294), probably through the inner lamella since 
mature virions were observed within the perinuclear cisternae 
(248). Budding through intracytoplasmic membranes of cells by 
BMV nucleocapsids was also reported (130, 294). Mature en­
veloped virions were observed extracellularly (248, 294) and 
within the cytoplasm, either free or within vacuoles (152, 
248). Occasional nucleocapsids, mostly in a degenerate state, 
were encounteied in the cytoplasm of BMV-infected cells (248). 
The intracellular development of Allerton virus, BMV and 
the Minnesota isolate were indistinguishable (27). 
Viral inhibition An oral isolate of the Allerton virus 
group was inhibited by BUDR and rifampicin (34) . A strain of 
BMV was also BUDR sensitive (191). Interferon was not de­
tectable in LMV-infected cells (223). 
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Physical and chemical studies 
Hemagglutination An oral isolate of the Allerton virus 
group did not hemagglutinate bovine, sheep, chick or guinea 
pig erythrocytes (34). 
Chemical sensitivity Bovine mammillitis virus and an 
oral strain were sensitive to ether and chloroform (34, 150, 
191). The former virus strain was also found to be sensitive 
to iodophor (151) but resistant to glycerol (150). 
Viral stability 
Temperature The temperature stability of some 
Allerton virus group strains are listed in Tabic 7. 
pH stability An oral isolate of the Allerton 
virus group (34) and BMV (191) were sensitive to exposure at 
pK 3 since most of the viable virus v;as dest^oyen afrpr in 
minutes at this pH. 
Freeze-thaw Three cycles of freezing and thawing 
did not affect the titer of BMV adversely (223). 
Nucleic acid The genomes of the viruses of the 
Allerton group probably consist of DNA since their replication 
was inhibited by BUDR (34, 191). Electron microscopic examina­
tion of differentially stained thin sections of cells infected 
with the Minnesota isolate resulted in typical reactions for 
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Table 7. Temperature sensitivity of the Allerton virus group 
Temperature Strain Stability Reference 
-50C BMV Titer unchanged in 1 month 223 
-20C BMV At least 4 months 150 
- 5C BMV At least 1 month 2 2 3  
4C BMV Titer unchanged in 1 month 2 2 3  
+ 20C BMV At least 105 days 2 2 3  
37C BMV Titer unchanged in 
8-day half life 
24 hours 
2 2 3  
50C BMV 60 minutes 223 
50C Oral 
isolate 30 minutes 34 
DNA in the virion cores (27). 
The base composition of BMV was found to be identical to 
that of Allerton virus (64 - 65 moles per cent guanine plus 
cytosine) (150). The molecular weight of Allerton and BMV 
DNA was calculated to be 34x10^ daltons (150). 
Pathogenicity 
Host range The susceptibility of various cell cultures 
to viruses of the Allerton group is listed in Table 8, Bovine 
mammillitis virus grew better in cells of bovine origin than 
in cells from several other animal species (253). One strain 
of BMV grew in HeLa cells (253) while another strain did not 
(223). Replication of mammillitis virus was observed in 
primary pig (191) and rabbit kidney cells (253) but not in pig 
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Table 8. The susceptibility of various cell cultures to 
viruses of the Allerton group 
Virus strain Cell culture Susceptibility Reference 
BMV Bovine lymph node 
cells 
Bovine kidney cells 
BHK (line) 
Bovine kidney cells 
(secondary) 
Bovine fetal testes 
Cat kidney 
Pig kidney 
Bovine fetal spleen 
Bovine fetal skin 
Rabbit kidney 
Dog kidney 
Human embryonic lung 
African green monkey 
MDBK (line) 
HeLa (line) 









































2 2 3  
223 
2 2 3  
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Table 8 (Continued) 
Virus strain Cell culture Susceptibility Reference 
BMV HeLa - 223 
PK 18 (line) - 223 
(line) - 223 
" Bovine conjunctiva + 150 
" Lamb testes + 150 
Oral isolate Bovine embryonic 
kidney + 34 
Allerton 
virus Calf kidney + 4 
Central African 
strain Bovine testis + 96 
" Ovine testis + 96 
Minnesota 
isolate Calf kidney + 294 
and rabbit kidney line cells (223). 
Animals Under natural conditions the viruses of 
the Allerton group cause disease in cattle (4, 97, 154, 294) 
and the African buffalo (233) . An African buffalo was highly 
susceptible to experimental infection with an Allerton-type 
virus (232) and a mild local reaction developed in the skin 
of a sheep and a pig but not in humans after intradermal 
inoculation with BMV (191). Local reactions developed in sheep 
and goats exposed to a Central African Allerton-type virus 
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strain by subcutaneous and intradermal inoculation and by skin 
scarification (97). 
Antibodies to the Allerton-type virus were detected 
in sera of African buffalo, giraffe, waterbuck, hippopotami, 
impala, eland, bushbuck and oryx (200). 
Laboratory hosts Bovine mammillitis virus pro­
duced localized skin lesions in rabbits (4, 47, 191, 225) and 
guinea pigs (150, 191, 225) and generalized lesions and death 
occurred in baby mice (4, 150, 225), and baby rats (225). 
A transitory, generalized skin reaction was observed in 
rabbits inoculated intradermally with the original Allerton 
isolates (4). Adult mice (150, 191, 225), adult rats 
(191, 225) and chicken embryos (150, 154) were refractory 
to BMV inoculated by various routes. Baby Chinese hamsters 
became stunted and died after intraperitoneal inoculation 
but were resistant to intradermal inoculation with BMV 
(225). 
The pathogenicity of an oral isolate for rabbits, guinea 
pigs, mice and embryonated eggs (34) , the Minnesota isolate 
for suckling laice and guinea pigs (294) , and a Central African 
isolate for mice, rabbits, guinea pigs and embryonated eggs 
(97) was similar to that described for BMV. Chickens were not 
susceptible to an oral isolate inoculated intradermally (34). 
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Disease in cattle 
Allerton virus was isolated from cases of lumpy skin 
disease (4) but experimentally caused mild generalized skin 
lesions (4, 288). The Minnesota isolate was made from 
dairy cattle with generalized skin lesions (294). The latter 
isolate produced generalized skin lesions even after intra­
dermal inoculation but only mild lesions developed on the 
teats and udders of experimentally infected cows (294). 
In many outbreaks of Allerton-type virus disease only 
teat and udder lesions were observed (47, 154, 191, 286). 
Severe teat and udder lesions were reproduced by intradermal 
inoculation with BMV strains (47, 153, 154, 225). Several of 
the BMV strains however, resulted in generalized skin lesions 
after intravenous inoculation (79, 225), but large virus doses 
were required to achieve this (225). Intradermal inoculation 
with BMV strains did not however result in generalized disease 
(79, 225). Muzzle and buccal lesions occurred in calves suck­
ling dams with bovine mamrnillitis (63, 113) and abortion did 
not occur in BMV-infected pregnant cows (225) . In a mamrnil­
litis epizootic in Central Africa caused by an Allerton-type 
virus, some generalized skin lesions were also observed (98). 
A virus with antigenic affinity to the Allerton virus 
group was isolated from an ulcer on the gingival tissues of a 
calf with gastro intestinal disease (34). The pathogenicity 
of this oral 3t "ain for cattle was similar to that of BMV (34). 
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An Allerton-type virus capable of eliciting severe disease 
in African buffalo was only mildly pathogenic for cattle since 
generalized skin lesions were produced in only 4 of 14 cattle 
inoculated intravenously with the virus (116) . 
Serology and immunity 
Serological and antigenic studies of the Allerton virus 
group have been conducted by serum virus neutralization (150, 
224), plaque reduction (253), immunodiffusion (150) and by 
ferritin-tagged antibodies (27). 
The Allerton-virus group was not serologically related 
to IBRV (34, 150, 253, 286), pseudorabies virus (34, 150, 
253, 286), herpes simplex virus (34, 150) or malignant 
catarrhal fever virus (150). The members of the Allerton virus 
group were found to be serologically homogeneous by several 
investigators (27, 34, 116, 294). 
Malignant Catarrhal Fever 
Virus (MCFV) 
History 
Malignant catarrhal fever has been known since the end of 
the 18th century in Europe (95) and at least since 1913 in the 
U.S. (278). Mettam (173) in 1323 quoted Gordon Gumming who in 
1850 wrote in his novel "Lion Hunter of South Africa" about 
the "danger of the oxen taking a horrible fatal illness, called 
by the boers SnoLsickness, which the cattle are very liable 
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to get from pasturing on ground frequented by black wilde-
beeste." The association of MCF (or Snotsiekte) with 
wildebeest in Africa was confirmed by Mettam in 1923 (173). 
The latter successfully infected a bovine with wildebeest 
blood on one occasion and was able to passage the disease from 
bovine to bovine using infected blood. He described the 
symptoms and lesions of the disease and concluded that the MCF 
agent was submicroscopic but remained closely associated with 
erythrocytes since he was not able to pass it through coarse 
Berkefeld filters. 
Outbreaks of MCF in Europe (20, 68), South Africa (48) 
and Kenya (193) in cattle have also been associated with con­
tact with sheep. Gotze and Liess (68) in 1929 described the 
peracute intestinal type, head and eye type and the mild form 
of the disease (45). Both the mild and the virulent head and 
eye forms of MCF were encountered by Daubney and Hudson in 
Kenya in 1938 (45) . These investigators transmitted the mild 
form only with some difficulty, failed to establish the 
disease in rabbits and found no association between this form 
of MCF and wildebeest (45). Daubney and Hudson (45) readily 
passaged the head and eye type in bovines and established 
this disease in rabbits. 
In 1929 Gocze and Liess (68) were the first to transmit 
the sheep type of MCF to bovines but were not able to infect 
rabbits. Others have repeated Gotze and Liess' transmission 
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experiments in cattle (103, 143) but some were unsuccessful 
(193, 196). 
The most significant development in the study of MCF 
occurred when Plowright et al. (199) in 1960 succeeded in iso­
lating the causative agent from a wildebeest. In 1965 Plow-
right et (201) concluded that this virus should be in­
cluded in the herpesvirus group. The etiology of the sheep-
associated MCF is still unknown (196). 
Ultrastructure 
Thin sectioning Cells infected with MCFV contained 
particles typical of herpesviruses (201). Random nucleo-
capsids, 90 nm in diameter, containing nucleoids about 40 nm 
in diameter were observed in the nuclei of infected cells 
(201) . 
Mature enveloped particles, about 130 nm in diameter, 
occurred extracellularly and within the cytoplasm of infected 
cells (201) . Cytoplasmic bodies consisting of mostly immature 
viral particles embedded in a dense granular matrix were ob­
served in infected cells (201). 
Negative staining Negatively stained preparations 
of MCFV revealed virions with typical herpesvirus morphology 
(201). Round or hexagonal capsids, approximately 100 nm in 
diameter consisting of hollow elongated capsomeres 12.5 nm 
by 9.5 nm, were observed (201). Most capsids were surrounded 
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by a loose membrane resulting in an overall virion size of 
140 nm to 220 nm (201). 
Replication and growth characteristics 
Replication Growth in cell cultures was slow and 
asynchronous even under the most optimum conditions since 8 
days usually elapsed before all cells in cell cultures showed 
cytopathic effects (201). 
Cytological changes Growth of MCFV in cell cultures 
was characterized by the development of large syncytia and 
type A intranuclear inclusions in affected cells (199, 201). 
Histochemistry Acridine orange staining of MCFV-
infected cells revealed thé accumulation of diffuse DNA-
containing material within nuclei, but the "halo" around 
intranuclear inclusions did not fluoresce (201). Nuclear 
inclusions were also found to contain DNA by feulgen staining 
of infected cells (201). 
Ultrastructural development Nucleocapsids developed 
randomly within the nucleus of infected cells (201) . These 
immature viral particles then accumulated near the nuclear 
membrane to form linear crystalline-like arrays while ramifying 
tubular formations of the inner lamella of the nuclear mem­
brane developed at the periphery of the nuclear matrix (201). 
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Mature virus particles were observed in the modified peri­
nuclear space and within vesicles in the cytoplasm (201). 
Viral inhibition Replication of MCFV was inhibited 
by lUDR but not by FUDR (201). 
Physical and chemical properties 
Malignant catarrhal fever virus was not retained by 
collodion filters with an apd of 430 nm (199) or plastic 
membrane filters with an apd of 300 nm (196) nor was the 
virus pelletted by centrifugation at 5,000 g for 30 minutes 
(199) . 
This virus was sensitive to ether and chloroform and to 
freezing (199). The virus was, however, readily stored by 
freezing using techniques designed to preserve cells (199). 
Since lUDR inhibits the replication of MCFV (201), its genome 
probably consists of DNA. This conclusion is supported by 
results obtained with acridine orange and feulgen staining of 
infected cells (201). 
Pathogenicity 
Host range 
Cell cultures The virus of MCF was originally 
propagated in bovine thyroid cells but also grew in bovine 
testis, bovine adrenal, sheep thyroid, rabbit kidney, a calf 
kidney line, and wildebeest kidney cells (199). 
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Animals Under natural conditions malignant 
catarrhal fever occurs in cattle (199) and domestic buffalo 
(196). Eland were infected experimentally with MCFV (196) 
and inapparent infections with this virus were very common 
in wildebeest (197, 198). 
Serological evidence of MCFV infection was detected in 
sera of hartebeest, topi, Thompson's gazelle and impala but 
not in Grant's gazelle or eland (5). Rabbits were susceptible 
to MCFV after intracerebral and intraperitoneal inoculation. 
Disease in cattle Inoculation of MCFV in cattle 
caused the virulent "head and eye" form of the disease with an 
extremely high mortality rate (199) even after 59 passages 
in calf thyroid cell cultures (196) . Pathological evidence 
suggested that the disease was due to a hypersensitivity 
. T o  (  1  O C  \  
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Serology and immunity 
Antibod:es to MCFV have been detected by serum-virus 
neutralization (201) complement fixation (196) and immuno­
diffusion (196). This virus was not related serologically 
to IBRV or varicella virus (201). Serological heterogeneity 
among various MCFV isolates has not been reported (197, 
201) . 
55 
Movar 33/63 Virus Group (M-Group) 
History 
Bartha et a]^. (12) in 1966 isolated a herpes-type 
virus, Movar 33/63, from calves with respiratory disease in 
Hungary. A serologically related virus (Riems strain) was 
isolated in East Germany from a case of malignant catarrhal 
fever in 1967 (131). Since then, antigenically related viruses 
were isolated in Russia from calves with respiratory disease 
(22, 23) and in Britain from spontaneously degenerating pri­
mary calf kidney cells (140). 
Ultrastructure 
Thin sections Intranuclear capsids, 75 nm - 100 nm in 
diameter, with or without nucleoids were observed in infected 
cells (131, 241). Remarkable resolution was obtained in one 
study since the hexagonal outline of capsids and the hollow 
capsomeres of the immature intranuclear herpes-type virions 
were discernible (241). 
Mature enveloped virions were observed extracellularly and 
within the cyLoplasra of infected cells (131,- 241). The 
virions of the Riems strain measured 140 nm - 160 nm in di­
ameter. 
Negative staining Electron microscopy of negatively 
stained preparations of the M-group viruses revealed capsids 
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with a hexagonal outline (23, 131, 241), icosahedral symmetry 
(23) and 162 hollow cylindrical capsomeres (23). The capsids 
were frequently surrounded by an envelope (23, 131, 241) on 
which an array of spikes (23, 131) measuring 3.0 nm to 3.5 
nm in length (23) occurred. 
The size of negatively-stained M-group virions and sub-
virion components are summarized in Table 9. Capsids measured 
after positive staining with uranyl acetate were approximately 
30 nm smaller than those observed after negative staining 
(23). 
Replication and growth characteristics 
Growth The M-group replicated to high titers in cell 
cultures (12, 22, 23, 131). Maximum titers of 10^'^ TCID^Q 
to 10^'^ TCID^Q per ml of cell culture fluid were reported 
(12, 22, 23, 131, 140). In one study virus titers were 
markedly influenced by cell type in which the virus replicated 
(140) -
Cytological changes Syncytium development did not 
occur in cell cultures infcctsd with M-group strains (131,-
241). The cytopathic effect produced by these viruses in cell 
cultures was characterized by rounding (131, 140, 241) and 
vacuolization in the cytoplasm (23, 140, 241) of the cells. 
Intranuclear inclusions characteristic of many herpesviruses 
developed within the nuclei of M-group-infected cells (22, 23, 
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Table 9. Size of negatively-stained virions and sub­
components of M-group 
Structure Virus Size (nm) Reference 
Nucleocapsid ST 66 
" Movar 33/66 
" Riems 
Capsomere length ST 66 
" Riems 
" Movar 33/66 
Capsomere diameter ST 66 
" Riems 
" Movar 33/66 
ST 66 Capsomere axial 
hole diameter 





























131, 140, 241). 
Histochemistry The intranuclear inclusions of M-
group-infected cells stained characteristically for DNA with 
acridine orange (22, 23, 131, 241), the feulgen procedure 
(131, 241), mei-hylgreen-pyronin (241) and chromalum-
gallocyanin (131). These inclusions, however, did not react 
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in the Sudan III, Best, and PAS staining procedures (131). 
Ultrastructural development Immature herpes-type 
virions first appeared in the nucleus of M-group-infected 
cells (131, 241). These virions apparently matured by budding 
through the inner lamella of the nuclear membrane into the 
perinuclear cisterna (241). Egress of these viruses from the 
perinuclear cisterna seemed to occur by a system of tubules 
(131, 241). Mature enveloped virions were only observed in 
the perinuclear cisterna and in tubules and vacuoles and cyto­
plasm of infected cells (131, 241). Envelopment of nucleo-
capsids also occurred in the cytoplasm by budding into vacuoles 
and tubules (241). 
Viral inhibition The replication of members of the M-
group was inhibited by lUDR (22, 23) and BUDR (140). 
Plaque formation Plaque formation by one strain of 
the M-group in cell cultures under an agar overlay has been 
observed (140). 
Physical and chemical properties 
Histochemical studies (22, 23, 131, 241) and inhibition 
studies with lUDR (22, 23) and BUDR (140) led to the conclu­
sion that the genome of M-group consisted of DNA. Members of 
the M-group were sensitive to ether (131), chloroform 
(12, 22, 23, 131, 140), a pH of 3.0 (12, 131), a pH of 4.0 
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(140), 0.125% trypsin (12, 131), sodium desoxycholate (131), 
saponin (22, 23), sodium dodecyl sulfate (22, 23) and heating 
at 50C for 30 minutes (22, 23, 131). The Russian strains 
ST 66 and LK, were, however, resistant to trypsin at a pH of 3.0 
( 2 2 ,  2 3 ) .  
The cations of magnesium (12, 22, 23), calcium (22, 23) 
and sodium (22, 23) did not stabilize viruses of the M-group 
against heating at 50C. Two strains of the M-group were still 
viable after storage at 4C for 12 months and did not lose 
any infectivity after lyophilization or after storage for 18 
months in the lyophilized state (23) . Hemagglutination or 
hemadsorption by infected cells was not observed with one 
strain of the M-group (22). 
Pathogenicity 
Host aubcepLillLy 
Cell cultures The viruses of the M-group grew in 
calf kidney (22, 23, 131, 140, 241), calf testis (23, 131, 
241), sheep kidney (12, 22, 23, 131), rabbit kidney (12, 131, 
140), calf thyroid (131), HeLa (140), MDBK (140), calf kidney 
line (22, 23), pig kidney (22, 23, 140), dog kidney (12), 
goat kidney (12), cat kidney (12) and chicken kidney cells 
(12). Guinea pig spinal cells (23) or chicken embryo fibro­
blasts did not support the growth of these viruses (22, 23). 
The Russian strains, ST 66 and LK, replicated poorly in sheep 
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and especially in swine kidney cell cultures (22, 23) but the 
British strain, CK 54, grew well in pig kidney cells (140). 
The latter strain grew poorly in HeLa cells (140) . 
Animals Rabbits, guinea pigs, rats and mice 
were resistant to the M-group viruses (22, 140). 
Disease in cattle The various members of the M-
group were isolated from a suspected case of MCF in a bovine 
(131), from calves with respiratory disease and keratocon­
junctivitis (12), from calves with bronchopneumonia (22, 23) 
and from spontaneously degenerating calf kidney cells (140). 
Experimental inoculation of calves with some strains 
elicited no signs of disease but some animals developed 
antibodies to the virus (12, 131) . The cell culture strain 
caused a pyrexia and seroconversion in experimentally in­
fected calves (140), while the Russian strains produced 
pyrexia, rhinitis, and conjunctivitis in calves (22, 23). 
Serology and_ immunity 
The serum-virus neutralization test failed to reveal 
a relationship between the M-group and IBRV (12, 22, 23, 131, 
140), pseudorabies virus (12, 131, 140), MCFV (131, 140), 
bovine virus diarrhea virus (12, 131), parainfluenza 3 virus 
(12, 22), herpes simplex virus (140), BHV (140) and four 
bovine adenovirus typos (12). 
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Serological comparison of various strains of the M-group 
failed to reveal any antigenic heterogeneity (22, 23, 131, 
140). A good antibody response developed in rabbits inocu­
lated with the LK strain (22). 
DN599 
History 
A virus (DN599) was isolated from a Maryland steer with 
respiratory symptoms by Mohanty et al. in 1971 (175). This 
virus has been shown to belong to the herpesvirus group (180) 
and produced pneumonia and conjunctivitis in experimentally 
infected calves (181) . 
Virus characteristics 
Electron microscopy of negatively stained virions of 
DN599 revealed typical herpes virions consisting of a capsid 
110 nm in diameter, surrounded by an envelope (180). Enveloped 
particles measured 150 nm in diameter. 
This virus caused a rounding up of bovine embryonic kidney 
cells in which typical Cowdry type A intranuclear inclusions 
developed (180). The replication of DN599 was inhibited by 
FUDR and it was heat, chloroform and acid sensitive (180). 
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Pathogenicity 
Calves infected intranasally and intratracheally with 
DN599 developed pneumonia, and conjunctivitis (180, 181) . 
Three of seven calves died 16 - 23 days post inoculation 
(181) . 
Serology and immunity 
This virus was not neutralized by antisera to herpes 
simplex virus, IBRV, Movar 33/63, MCFV, Allerton virus, 
pseudorabies virus, BMV and to canine, equine and avian 
herpes viruses (176, 180). 
Recovered calves did not develop neutralizing anti­
bodies to DN599 virus (181) nor were antibodies encountered 
in 84 sera from Maryland cattle (180). An antibody response 
was not elicited in calves, goats, rabbits, chickens and rats 
after multiple inoculations even when adjuvant was used in 
some cases (181). 
FTC 
History 
Smith et al^. (249) in 1972 isolated a virus from the 
trachea and retropharyngeal lymph nodes of Colorado feeder 
steers with upper respiratory disease. Four apparently 
identical isolates were made from 10 steers. Further studies 
were carried out on 2 of these isolates (FTCl and FTC2). 
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Virus characteristics 
These viruses (FTCl and FTC2) produced a rounding and 
granularity in secondary embryonic trachea cells in 4 to 5 
days. Intranuclear inclusions characteristic of many 
herpesviruses developed in infected cells. 
Electron microscopy of negatively stained virions re­
vealed typical herpes-type particles. Fully enveloped parti­
cles measured 115 - 150 nm while the spherical capsids with 
their hollow cylindrical capsomeres measured 90 nm - 105 nm 
in diameter. Unenveloped capsids measured 110 nm in diameter. 
Blebs were frequently observed in the envelope on which 5 nm 
to 6 nm projections occurred. 
Ultrathin sections of FTC-infected cells revealed 
scattered nucleocapsids, 90 nm to 110 nm, within the nuclei. 
Mature virions measuring 140 - 160 nm were observed in 
vacuoles within the cytoplasm of infected cells (249). 
Pathogenicity 
Viruses PTCl and FTC2 were associated with acute 
necrotizing, lymphocytic pharyngitis and tracheitis in 
cattle. Intratracheal inoculation of calves with FTCl re­
sulted in a dry hacking cough, tracheitis, interstitial 
pneumonia and fibrinous pleuritis (249) . 
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Serology 
The FTC viruses were not neutralized by IBRV antiserum, 




In 1968 Storz (262) isolated a herpes-like virus desig­
nated 66-P-347 from the spleen and blood leukocytes of a 
bovine with suspected MCF. 
Virus characteristics 
Capsids, with or without nucleoids, measuring 90 nm in 
diameter were observed in the nuclei of cells infected with 
this virus. Mature enveloped virions 120 to 140 nm in 
diameter were seen in the cytoplasm of infected cells. 
The replication of this virus was inhibited by BUDR and 
to a lesser extent by FUDR and it was sensitive to ether, 
chloroform and exposure to a pH of 3.0. The virus grew in 
bovine embryonic spleen, bovine embryonic thyroid and bovine 
embryonic adrenal cells but not in cells from the kidney or 
testis of bovine embryos. Syncytia did not develop in these 
cells and Cowdry type A intranuclear inclusions were observed 
in infected cells. These inclusions fluoresced charac­
teristically for DNA after acridine orange staining. 
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Pathogenicity 
This isolate (66-P-347) failed to produce disease in 
experimental cattle. 
Serology 
Storz's isolate was not neutralized by IBRV, pseudorabies, 
simian virus B or MCFV antisera. 
Isolate from a Lymphosarcomatous Bovine 
History 
In 1972 Van Der Maaten and Boothe reported the isolation 
of a virus from blood leukocytes of lymphosarcomatous cattle 
(279) . 
Characteristics of the virus 
L'lectron microscopic observation of cell cultures in-
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90 nm in diameter, with or without nucleoids 47 - 54 nm 
in diameter. Mature enveloped virions 140 - 160 nm in 
diameter occurred in the perinuclear cisternae and in cyto­
plasmic vesicles. Cytoplasmic and extracellular virions 
often contained shrunken eccentric cores and had much thicker 
and more electron-dense envelopes, imparting a somewhat 
crescent shape to the particles. 
Syncytia developed in infected bovine embryonic spleen 
cells but intranuclear inclusions were not encountered. The 
virus remained very cell associated. 
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Pathogenicity 
Rabbits, guinea pigs, mice and hamsters inoculated with 
the virus by a variety of routes remained normal. Calves 
were inoculated by several routes with the virus but no 
apparent disease resulted. The virus was reisolated from 
calves 4-12 months post inoculation. 
Serology 
No fluorescence was observed in cells infected with 
this virus after staining with IBRV or pseudorabies fluores­
cent antibody conjugates. Weak fluorescence occurred in in­
fected cells stained with a fluorescent antibody conjugate 
prepared from an infected cow's serum. Intense nuclear 
fluorescence and diffuse cytoplasmic fluorescence occurred 
in multinucleated cells in an indirect fluorescent antibody 
test using serum from one of the bovines from the herd where 
lymphosarcoma was present. 
Isolate from Reticulosarcoma 
in a Bovine 
Surin et al. (270) isolated a virus from the axillary 
lymph node of a cow with reticulosarcoma in 1969. The 
morphology and growth characteristics of this virus was typi­
cal of herpesviruses. 
This isolate was not recognized as a cause of reticulo-
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sarcoma, and rabbits, guinea pigs and mice were not sus­
ceptible to it. The virus was not related serologically to 
parainfluenza 3, IBR, pseudorabies or vesicular stomatitis 
viruses. 
Viruses from Miscellaneous Tumors 
Herpes-type viruses were isolated in bovine embryonic 
kidney and bovine embryonic testis cell cultures from 8 of 
10 urinary bladder tumors and 1 of 10 rumen tumors by Kamin-
jolo et (117). Immature herpes-like intranuclear virions 
(nucleocapsids) and mature enveloped extracellular virions 
were observed electron microscopically in thin sections of 
infected cells. Cytoplasmic virions, however, were similar to 
the intranuclear nucleocapsids. Examination of thin sections 
of tumor tissues revealed immature herpes-like virions in 2 
instances. 
Herpesvirus suis (Pseudorabies virus, PRV) 
Recently a very comprehensive review of PRV was pub­
lished by Kaplan (119). A detailed review of PRV literature 
will not be included in this discussion; instead the infor­
mation available on variation in PRV strains will be con­
sidered. 
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Virus modification The virulence of PRV became 
altered after passaging in chicken embryo cell cultures (157, 
245, 301), monkey kidney cell cultures (275), chicken embryo 
tissue cultures (102), mouse embryo tissue cultures (102) 
and chorioallantoic membranes of the developing egg (67). 
Passage of PRV in HeLa cells altered the antigenic properties 
of the virus but not its virulence (30). 
Modified strains were less virulent to rats (275) , 
rabbits (10, 67). mice (102), cats (246), swine (247), calves 
(157, 245, 246, 301) and sheep (10, 247, 301). 
Reduced virulence in laboratory animals was judged by 
increased incubation period (67, 102), absence of pruritus 
(67, 102, 246, 275) and increased survival (10, 247). During 
attenuation procedures, loss of virulence occurred for swine 
before it did for cattle and sheep (245, 246, 247). Ante-
mortal pruritis was not observed in laboratory animals in­
fected with partially attenuated PRV strains (246, 247). 
Further attenuation of such stra. is was followed by in­
creased survival when laboratory animals were infected (246, 
247) . 
Virulence markers 
Plaque size Reduced virulence of attenuated PRV 
strains was associated with increased plaque size in cell 
cultures (157, 246, 247, 275) but in 2 instances modified 
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strains produced smaller plaques (10, 30). Subculturing of 
some large-plaque variants with reduced virulence resulted in 
the development of occasional small and medium plaques (247) . 
These latter small plaque variants underwent further modifi­
cation more readily than their parent strains (247). 
Cytopathic effect A change in the type of cyto-
pathic effect produced in cell cultures by PRV has been 
associated with a change in virulence of the virus (10, 30, 
275). In these studies virulent strains caused syncytia in 
rabbit kidney (30), monkey kidney (10, 275) and chicken 
embryo cells (10) but the modified strains caused a rounding 
of cells. 
However, in one study virulent and avirulent strains 
resulted in a similar rounding of chicken embryo cells (246) . 
Replication In some studies the replication 
(157, 275) and growth curves (275) of modified and virulent 
strains were found to be similar. However, in one study 
modified large-plaque strains yielded 2-3 logs more virus 
and grew more rapidly than parent strains in chicken embryo 
cells (246). Small-plaque avirulent variants of partially 
attenuated large-plaque strains replicated far more slowly 
in chicken embryo cells than their parent strains (247). 
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Antigenic variation Attenuated strains were in­
distinguishable from virulent strains using cross neutraliza­
tion (10, 30, 247, 275). Antigenic variation detectable by 
serum neutralization did, however, occur with one PRV strain 
after 75 passages in HeLa cells but this was not associated 
with a change in virulence (30). 
Field strains Skoda et in 1964 isolated a strain 
of PRV (SUCH) which produced disease in cattle only after 
intracerebral inoculation (246). This strain possessed 
several of the markers Skoda et al^. associated with a reduc­
tion of virulence in cell-culture-attenuated strains. The 
SUCH isolate did not elicit pruritus in rabbits after intra­
muscular inoculation and formed larger plaques in and caused 
more rapid degeneration of chicken embryo cell cultures. 
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MATERIALS AND METHODS 
Cell Cultures 
The Madin Darby bovine kidney cell line (MDBK) (141) and 
a strain of cells (EBT) derived from embryonic bovine tracheal 
tissue^ were used in this study for the propagation and assay 
of viruses. 
Cell Culture Media 
Liquid medium 
Both MDBK and EBT cells were propagated in Eagle's mini­
mum essential medium with Earle's salts, L-glutamine, and non-
2 
essential amino acids (MEM) . 
Solid media 
Various solid and semisolid media were used as overlays 
on cell monolayers. The basic ingredient of all the over­
lays was Eagle's basal medium with Hanks' salts and L-
2 glutamine (BME) . The ingredients used for solidification of 
the overlays included 0.6 per cent Special Agar Noble^, 0.3 
per cent agarose^, 2 per cent methyl cellulose^ with a 
^Supplied by P. C. Smith, National Animal Disease 
Laboratory, Ames, Iowa. 
O 
Grand Island Biological Co., Grand Island, New York. 
^Difco Laboratories, Detroit, Michigan. 
^Colab Laboratories, Inc., Glenwood, Illinois. 
Dow Chemical Co., Midland, Michigan. 
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viscosity of 4,000 centipoises, and 2 per cent methyl cellu­
lose with a viscosity of 15 centipoises^. Prior to use, 
the methyl cellulose was purified with ether and alcohol as 
described by Hotchin (89). 
2 In some instances protamine sulfate (100 yg per ml) 
and/or diethylaminoethyl (DEAE) dextran^ (100 yg per ml) were 
included in the overlays in attempts to enhance the develop­
ment of viral plaques in cell monolayers. 
Propagation of Cells 
Madin Darby kidney cells less than 48 hours old and EST 
cells were removed from the surfaces of culture containers 
with a trypsin-versene solution consisting of 0.8 per cent 
NaCl, 0.04 per cent KCl, 0.1 per cent dextrose, 0.06 per cent 
NaKCO„, 0.05 ueir cent trvpsm and 0.02 oer cenL disouium 
J 
ethylene diamine tetraacetate (versene). Madin Darby kidney 
cells older than 48 hours were removed with a solution con­
taining 0.8 per cent NaCl, 0.02 per cent KH2^^4' 0.115 per cent 
NagHPO^, 0.2 per cent trypsin and 0.1 per cent versene. 
The dispersed cells were centrifuged at 125 X g for 10 
^Fisher Scientific Co., Fair Lawn, New Jersey. 
2 Nutritional Biochemicals Corp., Cleveland, Ohio. 
3 
Pharmacia Fine Chemicals Inc., Piscatav/ay, New Jersey. 
^Difco Laboratories, Detroit, Michigan. 
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minutes and resuspended to a concentration of 3.5X10^ per ml 
in MEM with 10 per cent fetal calf serum (FCS)^. Twenty 
2 
ml of this cell suspension was placed in 75 cm plastic 
2 3 
cell culture flasks , 2 ml in Linbro plate wells , or 1 ml in 
2 16X125 mm plastic cell culture tubes . Half gallon cell 
4 7 production roller bottles were seeded with 5.4X10 cells 
suspended in 50 ml of MEM with 10 per cent FCS. The cells 
in the flasks, tubes and Linbro plates were incubated at 37C 
in a humidified incubator with an atmosphere containing 5 
per cent COg. The roller bottles were tightly sealed and 
rolled at 37C at a rate of 0.25 rpm. In some instances the 




The virus strains used in this study are listed in 
Table 10. 
^Grand Island Biological Co., Grand Island, New York. 
n 
Falcon Plastics, Oxnard, California. 
^Model FB-6TC, Linbro Chemical Co., Inc., New Haven, 
Connecticut. 
A  
'Bellco Glass, Inc., Vineland, New Jersey. 
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Table 10. Origin and source of bovine herpesvirus strains 
Strain Origin Source 
H. bovis 650 respiratory tract C. J. Mare 
H. bovis 1309 II II II 
H. bovis K22 genital tract D. G. Mc Kercher 
H. bovis Steiner II II II 
H. bovis Jensal vaccine Jensal Laboratories^ 
H. bovis Diamond vaccine Diamond Laboratories^ 
DN599 respiratory tract ATCC^ 
FTCl II tl P. C. Smith^ 
Vll leukocytes M. J. Van Der Maaten^ 
^Jensen-Salsbery Laboratories, Kansas City, Missouri. 
^Diamond Laboratories Inc., Des Moines, Iowa. 
^American Type Culture Collection, Rockville, Maryland. 
LNdCXOllctX uciajoj_ a. uwj. f y «Vct . 
viral propagation 
All virus strains were replicated either in MDBK cells 
or EBT cells. One- to B-day-old cells were infected by 
replacing their growth mediuiû with MEM plus 5 per cent FCS 
containing sufficient virus to provide an infection rate of 
1 to 10 plaque forming units (pfu) per cell. The virus 
preparation was replaced with MEM plus 5 per cent FCS after 
2 hours at 37C. After all the cells had degenerated 
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the cells and culture fluids were harvested and stored in 
sterile glass vials at -70C. 
In some instances the viruses were added to the growth 
medium of cells immediately after the latter had been placed 
in flasks. 
Assay 
Viruses were assayed by the plaque method. Firstly, 
6-8 serial 10-fold virus dilutions were made in sterile 
saline G (0.11 per cent glucose, 0.8 per cent NaCl, 0.04 
per cent KCl, 0.0153 per cent NagHPO^, 0.015 per cent 
KH2PO4, 0.015 per cent MgSO^-VHgO, 0.1 per cent lactalbumin 
hydrolysate, 1.6 mg per cent CaCl2-21120 and 0.12 mg per cent 
phenol red). Serial 10-fold dilutions were sometimes carried 
out in MEM plus 10 per cent rabbit serum^. The medium was 
removed from Linbro plate wells containing monolayers of EBT 
cells and 1 ml of every serial virus dilution was inoculated 
into each of 2 wells. The H. bovis strains were allowed 
to adsorb to cells for 1 hour at 37C after which the virus 
preparation was replaced with 2 ml of MEM with 4 per cent 
FCS and 0.5 per cent specific anti - H. bovis rabbit seruiTi. 
These cells were then incubated for 48 hours when they were 
fixed by the addition of 20 per cent formalin into each well. 
^Grand Island Biological Co., Grand Island, New York. 
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After 10 to 20 minutes of fixation the formalin was rinsed out 
of the wells with distilled water and the cells were stained 
by pipetting 1 ml of 5 per cent crystal violet in 20 per cent 
ethanol into each well. The stain was rinsed out of the 
Linbro plate wells with distilled water 5 minutes later and 
after the plates had dried at room temperature the plaques in 
each well were counted and recorded. Plaque sizes were 
measured using an inverted microscope^ fitted with a calibrated 
eyepiece. 
The remaining three viruses (DN599, Vll, FTCl) were 
adsorbed onto cells for 12 to 48 hours at 37C after which the 
virus preparation was removed and 2 ml of an BME-agar overlay 
supplemented with 10 per cent rabbit serum was pipetted 
into each Linbro plate well. These plates were incubated at 
37C for a further 3 to 8 days before the cells were fixed 
as described above. The overlay was carefully removed with 
a scalpel and the cells were stained as described. 
A technique was also developed whereby cells were simul­
taneously seeded into Linbro plates and infected with DN599, 
FTCl or Vll. The viruses were diluted in medium as described 
previously and the cells were prepared at double the concen­
tration used for seeding. One ml of a virus dilution and 1 ml 
of the cell suspension were then inoculated into each of two 
^Unitron, Newton Highlands, Massachusetts. 
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wells. The overlay was placed over these cells 24 hours 
later as described above. 
Photographs were taken of the virus plaques using a 
Leitz camera fitted with a bellows attachment^. Light 
2 from two BBA no. 1 Photoflood bulbs was reflected with a 
mirror upwards through a Linbro plate containing the stained 
cell monolayers. Color transparencies were taken at a 
3 distance of 18 inches using Kodachrome II Professional film 
suitable for tungsten illumination. Black and white negatives 
were prepared from the transparencies and prints were made 
from the negatives. 
Plaque purification 
All the viruses used in this study except the vaccine 
strains were cloned by plaque purification. The H. bovis 
strains were cloned 3 times while DN599, FTCl and VI1 
were cloned twice. Plaque purification was achieved by first­
ly carrying out a virus assay as described previously except 
that an agar overlay was used in all instances. The cells 
were not fixed and stained after plaque development but instead 
^Ernst Leitz, Wetzlar, West Germany. 
2 General Electric Co., Cleveland, Ohio. 
•5 
Eastman Kodak, Rochester, New York. 
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the virus was collected from well-separated individual 
plaques with a 1 ml tuberculin syringe, fitted with a 25 
gauge needle. The material collected in the syringe was 
expelled into the growth medium of cells in tubes. When all 
the cells had degenerated in these tubes , the cells and their 
culture fluids were collected and stored at -70C. 
Antibody Production 
Viral antisera 
Viral antigen Viral preparations used for immuniza­
tion of rabbits were grown in 8 flasks of cells and partially 
purified by differential centrifugation. The cells were in­
fected as described above and after all cells had degenerated 
they were harvested together with their culture fluids. This 
crude virus preparation was then subjected to 3 cycles of 
rapid freezing and thawing in liquid nitrogen and a 37C 
water bath, respectively. The virus preparation was centrifuged 
for 30 minutes at 2000 X g at 2C after which the supernatant 
fluid was collected and centrifuged at 30,000 X g for 90 
minutes. The resulting pellet was resuspended in physio­
logical saline and centrifuged again at 2000 X g and 30,000 
X g as described above. The final pellet was resuspended in 
4 ml physiological saline and stored at -70C. 
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Immunization procedure with viral antigens One ml of 
the above viral antigen was emulsified in 1 ml of complete 
Freund's adjuvant^ which was then inoculated intradermally 
and into the rear foot pads of a New Zealand White rabbit. 
Each foot pad received 0.2 ml while 0.1 ml was inoculated 
intradermally at 16 sites. Three weeks later a similar inocu­
lation was made except that incomplete Freund's adjuvant^ 
was used and the foot pad inoculations were not repeated. 
After a further 3 weeks, one ml of the viral antigen was 
administered intravenously to the rabbits. 
The rabbits were bled by cardiac puncture 10 days after 
the first inoculation and again 10 days after the last inocu­
lation. The serum collected from these blood samples was 
stored at -20C and labeled "early serum" and "late serum", 
respectively. 
Anti-rabbit globulin sera 
Preparation of rabbit globulin antigens Rabbit 
globulins were prepared from normal rabbit serum by 2 cycles 
2 
of gel filtration through a Sephadex G200 column. The 
protein concentration in the 19S and 7S preparations was 
measured by the Dowry method (137). The 19S globulin 
preparation was tested for contamination with 7S globulins by 
^Difco Laboratories Inc., Detroit, Michigan. 
2 
Pharmacia Fine Chemicals, Piscataway, New Jersey. 
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Immunoelectrophoresis and by immunodiffusion. The IS globulin 
preparation was tested for 19S contamination in the same way. 
Immunization procedure with rabbit globulins Leghorn 
roosters were immunized 3 times at 3-week intervals with 
3 mg of either 19S or 7S rabbit globulins. The globulin 
preparation was emulsified in an equal volume of complete 
Freund's adjuvant for the first inoculation. Incomplete 
Freund's adjuvant was used for the second inoculation while 
the third inoculation with the globulin preparations was 
administered intravenously without adjuvant. Subcutaneous 
inoculations were made when adjuvant was employed and a maxi­
mum of 0.2 ml was injected per inoculation site. The roosters 
were bled by cardiac puncture 10 days after the third inocula­
tion. The serum from these blood samples was stored at 
-20C. 
Absorption of antisera and globulin preparations 
Antisera and globulins derived from such sera were 
absorbed one to 3 times with either 12X10^ EBT cells or 
20X10° MDBK cells per ml of serum. Firstly, the cells were 
scraped off the growth surface in a plastic flask with a 
"rubber policeman" (a short glass rod inserted into latex 
rubber tubing). The cells were pelletted by centrifugation 
in a conical tube at 800 X g for 10 minutes and then re-
suspended in 0.3 - 0.5 ml physiological saline and then 
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subjected to 3 cycles of freezing and thawing. Serum was 
then added to the cell preparation and absorption was allowed 
to take place for 2 hours at room temperature with occasional 
agitation. The cell-serum mixture was then centrifuged for 
20 minutes at 800 X g and the supernatant fluid was filtered 
through a 220 nm plastic membrane filter^ and stored at 4C. 
Chromatography 
Gel filtration 
Sephadex G200 Rabbit 19S and IS globulins were pre­
pared by filtering rabbit sera through a column of Sephadex 
G200. The Sephadex G200 was hydrated in a 0.1 M, pH 8.0 
TRIS-HCl buffer containing 1 M NaCl and 0.2 per cent NaN^• 
The gel was packed in a 2.5 x 90 cm column in a glass 
2 
chromatography tube with an adjustable plunger. Four-ml serum 
samples were run into the lower end of the column and buf­
fer was allowed to run upwards through the column at a rate of 
12 ml per hour. The absorbance of the eluate at 280 nm was 
3 4 determined with an UV-monitor and a fraction collector was 
^Millipore Filter Corp., Bedford, Massachusetts. 
2 Glencoe Scientific, Inc., Houston, Texas. 
^Model UA4; Instrumentation Specialties Co., Inc., 
Lincoln, Nebraska. 
^Model 272; Instrumentation Specialties Co., Inc., 
Lincoln, Nebraska. 
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used to collect the eluates. The contents of the tubes 
corresponding to the absorbance peaks registered on the 
chart recorder were pooled and the protein content was 
measured by the Lowry method (137). Two ml PCS was added to 
each 19S globulin preparation to prevent aggregation of the 
latter. The pooled serum protein fractions were concentrated 
to 4 ml either by ultrafiltration at a pressure of 10 lbs per 
square inch or by pressure dialysis at a negative pressure of 
18 lbs per square inch. The globulin preparations were then 
dialyzed for 3 days against 6 changes of saline G at 4C. 
Prior to use in the neutralization kinetics procedure , the 19S 
globulin preparations were sonicated for 30 seconds with a 
Bronwill Biosonik sonicator^ set at the 10 per cent position 
in an attempt to disperse the globulin molecules. 
Sephadex G25 Free fluorescein isothiocyanate (FITC) 
was removed from crude FITC-protein conjugates by filtration 
through a 1.5 x 90 cm column of Sephadex G25 gel. The proce­
dure was similar to that used with Sephadex G200 except that 
a n.01 M. dH 7.5 Na^HPO.-NaH^PO, buffer containing 0.15 M 
• - ZI ;C «± 
NaCl and 0.2 per cent NaN^ was used. A flow rate of approxi­
mately 50 ml per hour was used. The FITC-protein eluates were 
collected by visual tracing of the fluorochrome-
^Will Scientific, Inc., Rochester, New York. 
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Ion exchange chromatography 
Fluorescein isothiocyanate-chicken 7S globulin conjugates 
were subjected to ion-exchange chromatography using a modifi­
cation of a previously described procedure (205). Diethyl-
aminoethyl (DEAE) cellulose^ was activated by two alternate 
washings with 0.1 N NaOH and 0.1 N HCl. The slurry was then 
rinsed with distilled water until the eluate pH approached 
7.0 after which the slurry was washed several times with 
either a 0.1 M or a 0.3 M, pH 6.8 NaHgPO^-NagHPO^ buffer and 
stored overnight in this buffer. 
A column, 1 x 12 cm, was packed and rinsed several times 
with the same buffer. Four ml of a FITC - IS globulin 
conjugate was first dialyzed for 12 hours against the above 
buffer and then placed on top of the column. The passage of 
the FITC globulins through the column was followed by visual 
tracing and collected in a tube. 
Immunoelectrophoresis 
Rabbit globulin preparations were tested for purity 
by immunoelectrophoresis. Alcohol-cleaned 1x3 inch glass 
slides were covered with a thin film of a 0.1 per cent 
agarose, 0.5 per cent glycerine and 0.03 per cent Tween 80 
solution and allowed to cool. The slides were placed on a 
^Schleicher and Schuell, Inc., Keene, New Hampshire. 
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level surface and 4.5 ml of 0.6 per cent agarose and 0.2 per 
cent Special Agar Noble^ in a 0.075 M, pH 8.6 barbital buffer^ 
was carefully layered on each slide and allowed to solidify 
at room temperature. An Immunoelectrophoresis pattern was 
3 
cut into the agarose-agar-coated slides with a gel punch. 
The agar was removed from the sample wells and three yl 
samples were placed in these wells. Four slides were electro-
phoresed together for 2 hours using a current of 42 amps 
and a potential of 115 volts. The agar was then removed 
from the antiserum channel which was then filled with sheep 
4 
anti-rabbit globulin . After incubation at room temperature 
for 18 hours, the slides were examined while illuminated with 
indirect fluorescent light. 
Immunodiffusion 
Immunodiffusion was carried out on 1 x 3 inch glass 
slides covered with 4.5 ml 0.8 per cent Special Agar Noble 
in physiological saline. Two-mm wells were cut in the agar 6 
mm apart and arranged in a circle around a 2-mm central well. 
The central well was filled with rabbit globulin prepara-
^Difco Laboratories, Detroit, Michigan. 
2 Harleco, Philadelphia, Pennsylvania. 
•3 
LKB, Stockholm, Sweden. 
^Pentex Inc., Kankakee, Illinois. 
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tions while the peripheral wells were filled with sheep anti-
rabbit globulin.^ The slides were incubated for 48 hours 
and examined for lines of precipitation while illuminated 
indirectly with fluorescent light. 
Preparation of FITC Conjugates 
A modification of a previously described method (205) 
2 
was used to label chicken globulins with FITC . Gel filtra­
tion with Sephadex G200 was employed to prepare 7S globulins 
from chicken anti-rabbit globulin sera. The chicken 7S 
globulin fractions were dialyzed for 72 hours against 6 changes 
of 0.05 M, pH 9.0 NagCOg-NaHCOg buffer. Sufficient FITC to 
provide a protein to FITC ratio of 40:1 was dissolved in enough 
buffer so that when the protein and FITC solutions were mixed, 
the final protein concent: rr'r inn won là be one per cent. While 
the 7S globulin preparation was stirred at 4C on a magnetic 
stirrer, the FITC solution was slowly added in a dropwise 
fashion. Stirring was continued for another 12 hours at 4C 
after which the unbound FITC was removed by filtration through 
a Sephadex G25 column. The FITC-conjugated 7S globulins were 
then subjected to ion-exchange chromatography and stored at 
-70C. Immediately before the conjugates were used, they were 
^Pentex Inc., Kankakee, Illinois. 
2 
BBL, Cockeysville, Maryland. 
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absorbed with EBT cells as described earlier. 
Indirect Fluorescent Antibody 
Test (FAT) 
Viral preparations tested by the FAT were prepared in 
1.1 X 2.4 cm tissue culture chambers mounted on glass 
slides^. Four such chambers were mounted on each glass 
slide. Embryonic bovine trachea cells were grown in the 
chambers by seeding 1.5X10^ cells suspended in 0.5 ml of growth 
medium per chamber. The cells were infected with lo'^ pfu of 
virus per chamber and when 50 to 75 per cent of the cells 
had degenerated they were fixed for 10 minutes at room 
temperature in acetone. The slides were used immediately or 
stored at -70C for up to 8 weeks. 
The FAT was carried out by first hydrating the infected 
e >*> y" a S r* rr V Hmnc f> fVI M "oW n S TvTpW tJO —NTa WPO 
buffer containing 0.15 M NaCl (PBS) over the surface of the 
cells in a chamber. Four drops of a suitable dilution of anti­
serum or globulins derived from such sera were then placed in 
the chamber. The slides were then placed in a humidified 
container, incubated for 30 minutes at 37C, and washed in 3 
changes of PBS for 30 minutes. The slides were air dried, 
hydrated as before and 4 drops of a suitable dilution of an 
anti-rabbit globulin - FITC conjugate were placed in each 
^Model 4804; Lab Tek, Westmont, Illinois. 
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chamber. Incubation and washing was done as before. 
Coverslips were mounted on the specimen slides using a 
mounting medium consisting of 9 parts of glycerine and one 
part of PBS. The slides were examined with a Zeiss Universal 
Fluorescence microscope^ using the blue BG 3/4 excitatory 
filter and the 53 barrier filter. Photographic transparencies 
2 
were taken with a Leica camera loaded with High Speed 
Ektachrome film? which was developed by the ESPl process^. 
Black and white and color negatives were made from the 
transparencies from which prints were made. 
Serum-Virus Neutralization 
Reciprocal serum-virus neutralization tests were carried 
out with DN599, FTCl, and Vll viruses. Each virus was 
diluted in MEM supplemented with 10 per cent PCS to a con­
centration of 200 pfu per ml. Serial 2-fold dilutions of 
antisera were also made in MEM with 10 per cent PCS. Anti-
sera were heated for 30 minutes at 56C prior to the test. Two 
ml of each virus preparation was mixed with 2 ml of each anti-
ser%^ dilution and incubated at 4C Overnight. The surviving 
^Carl Zeiss, Oberkochen, West Germany. 
2 
Ernst Leitz, Wetzlar, West Germany. 
^Eastman Kodak Co., Rochester, New York. 
^Kodak Processing Laboratories, Chicago, Illinois. 
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virus was assayed as described previously. 
The reciprocal of the antiserum dilution which resulted 
in a 50 per cent reduction of the plaque count was considered 
to be the antiserum titer. The 50 per cent end point was 
estimated by the method of Reed and Muench (209). 
Neutralization Kinetics 
Kinetic neutralization was carried out as described by 
4 
McBride (158). The viruses were diluted to contain 2x10 
pfu per ml in saline G with one per cent PCS chilled to 4C. 
One tenth ml chilled fresh guinea pig serum was added to 0.5 
ml of the diluted virus preparation. One half ml of chilled 
rabbit anti-serum or purified globulins derived from such 
sera was added to the virus mixture and rapidly mixed. A 0.1 
ml aliquot of the mixture was immediately diluted 100-fold by 
blowing it into 9.9 ml of chilled saline G plus one per cent 
PCS. The rest of the virus - antiserum mixture was incubated 
in a waterbath at 37C for 15 minutes. One tenth ml aliquots 
were taken every 5 minutes from the incubating mixture and 
diluted 100-fold as before. The amount of virus present in 
each diluted aliquot was then determined by the plaque method. 
The growth medium was removed from the wells in Linbro plates 
containing EBT cell monolayers. One ml of each diluted 
aliquot was placed in each of 2 wells and adsorption was 
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allowed to take place for one hour at 37C. The rest of the 
plaguing procedure has been described earlier. 
In some instances the saline G diluent was replaced with 
MEM plus 10 per cent FCS. In other instances the interval 
between the removal of aliquots from the mixture was extended 
to 15, 30 or 45 minutes. For control purposes guinea pig 
serum was sometimes replaced with saline G and normal serum 
was occasionally used instead of antiserum. 
The rate of neutralization of a virus by a particular 
antiserum was judged in 2 ways. Firstly, the neutralization 
slopes were plotted graphically on a semilogarithmic scale with 
virus concentration (pfu per ml) on the logarithmic ordinate 
versus time (minutes) on the linearly scaled abscissa. The 
neutralization constants (K) were calculated using the fol­
lowing formula: 
K = D/t 2.3 log Vo/Vt 
Where: 
K is the neutralization constant. 
D is the antiserum dilution. 
Vo is the virus concentration at time zero. 
Vt is the virus concentration at time t. 
Secondly, "normalized" K values were calculated for the various 
virus strains where neutralization with the homologous anti­
serum was arbitrarily set at 100 and neutralization of the 
other strains by the same antiserum was rated proportionately 
90 
according to their K values. Statistical estimates of the 
virus neutralization slopes were made by linear regression and 
these slopes were then compared using the Student's t test as 
described by Steel and Torrie (252b). 
Immunoelectroosmophoresis (lEOP) 
The lEOP procedure was basically carried out as described 
by Hansson and Johnson (87) and Jeansson (109). 
Preparation of viral antigen 
Monolayers of MDBK cells in 2 cell production roller 
bottles were infected with virus at a multiplicity of in­
fection of 10 pfu per cell. Virus was allowed to adsorb for 
2 hours at 37C at a speed of 0.5 rpm after which the virus 
preparation was replaced by 25 ml of MEM plus 5 per cent PCS. 
The bottles were then rolled at 0.7 rpm at 37C until all cells 
had degenerated. The cells and culture fluids were harvested 
and stored at -70C. When needed, the virus preparations were 
thawed and ultrasonically treated 4 times for 30 seconds with 
a Bronwill Biosonik sonicator^ set at the mcximum position. 
The virus preparation was then centrifuged at 3.000 X g 
for 60 minutes at 4C. The supernatant fluid was used as 
the test antigen. Before use, the test antigen was con­
centrated to 2 ml by pressure dialysis and dialyzed against 
^Will Scientific, Inc., Rochester, New York. 
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a 0.075 M barbital buffer^ with 0.1 per cent NaN^. The 
pelletted cell debris was used to absorb antisera or globulins 
derived from such sera in an attempt to improve their speci­
ficity. The absorption regimen has been described earlier. 
Preparation of slides 
Detergent-cleaned 3.25 x 4 inch glass slides were covered 
with two thin layers of a hot (56C) solution of 0.2 per cent 
agarose, 0.5 per cent glycerine and 0.03 per cent Tween 80 
with a cotton-tipped applicator. The slides were placed on a 
level surface and covered with 13 ml of a hot solution of 0.75 
per cent agarose in 0.075M barbital buffer. 
Holes, 2 mm in diameter and 6 mm apart, were cut in the 
agarose layer after the latter had gelled and the slides were 
stored in a humidified container at 4C for up to 2 weeks. 
E1ec trophore sis 
Eight yl of the viral antigen was placed in the wells 
closest to the cathode while 8 yl samples of antiserum or 
globulins derived from such sera were placed in the wells 
2 
closest to the anode of the electrophoresis chamber . rhe 
hollow electrophoresis chamber walls and floor were cooled 
with continuously circulating tap water to approximately 13C 
^Kallestad Laboratories, Minneapolis, Minnesota. 
2 
Deluxe model; Gelman Instrument Co., Ann Arbor, Michigan. 
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while electrophoresis was carried out for 50 - 50 minutes 
at a potential of 7 volts per cm. 
Staining procedure 
The electrophoresed slides were incubated at room tempera­
ture in a humidified container for 24 hours after which the 
slides were placed in physiological saline overnight. The 
slides were then covered with moist filter paper and dried 
at 37C. The dried slides were stained with 0.2 per cent 
Coomassie Brilliant Blue^ in a mixture of acetic acid, methanol, 
and water (1:5:5 ratio) for 15 minutes and destained in the 
acetic acid, methanol, and water mixture for 20 minutes. 
The slides were then examined for lines of precipitation 
between the antigen and antiserum wells. The stained prepara­
tions were photographed as described in the virus assay 
section. 
Radial Immunodiffusion (RID) Test 
The RID test used was a modification of the procedure 
described by Mancini et al. (144) . 
Viral antigens 
Viral antigens were prepared as for the lEOP test. Eight 
yl samples of antigen were used for the RID test. 
^Colab Laboratories, Inc., Chicago Heights, Illinois. 
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Slide preparation 
A 1.6 per cent suspension of agarose in 0.075 M barbital 
buffer with 0.1 per cent NaN^ was dissolved by heating to-lOOC. 
The agarose solution was cooled to 56C in a waterbath and 
then mixed with an equal volume of various dilutions of virus 
antisera or globulins derived from such sera. Antiserum 
dilutions were made in the above buffer. Detergent-cleaned 
lx3-inch glass slides were laid on a level surface and covered 
with 4.5 ml of the agarose antiserum mixtures. Wells, 2 mm in 
diameter and 10 - 20 mm apart were cut into the gels after 
they had solidified at room temperature. The slides were used 
immediately or stored at 4C in a humidified chamber for up to 
2 weeks. 
Test procedure 
Viral antigen (8 yl) was placed in each well and incubated 
at room temperature in a humidified container. Observations 
for zones of precipitation around the wells were made daily for 
4 days by examining slides illuminated indirectly with fluores­
cent light. Similar illumination was used to photograph un­
stained preparations. In some instances the slides were dried 
and stained as described earlier. Photographs of stained 




Method of plaguing 
Various methods of plaguing H. bovis strains in cell 
monolayers were investigated. Embryonic bovine trachea cells 
were preferred to MDBK cells since the latter tended to pile 
up in the eerier of the Linbro plate wells resulting in very 
uneven cell monolayers. Virus plagues which developed in the 
outer areas of MDBK monolayers were often guite indistinct. 
Monolayers of EBT cells developed very uniformly and lasted 
at least 3 weeks before use. 
Herpesvirus bovis plagues developed in cell monolayers 
under agar overlays after 3 to 4 days incubation. These 
plaques were occasionally fairly indistinct and difficult 
to count which, together with the inconvenience of using 
agar overlays with large numbers of samples, prompted investi­
gation into the use of other methods. 
The development of virus plagues in cell monolayers with 
a liquid overlay consisting of MEM supplemented with 4 per cent 
PCS and various levels of specific virus antiserum was investi­
gated. Antiserum concentrations greater than 2 to 4 per cent 
were found to be toxic to the cells. Absorption of antiserum 
with EBT cells before its use in the liguid overlay con­
siderably reduced the toxic effects of the antiserum. The 
95 
minimum antiserum concentration which still allowed plaque 
formation was found to be 0.125 to 0.25 per cent. Concen­
trations of antiserum in liquid overlays below this minimum 
level resulted in indistinct plaques which were difficult to 
count. The use of antiserum in a MEM overlay (plaquing medium) 
was a very convenient plaquing method and resulted in clearer 
plaques and more consistent plaque counts than with an agar 
overlay. A 0.5 per cent antiserum concentration was subse­
quently used in the plaquing medium in all assay experiments 
with H. bovis strains. This plaguing medium was suitable for 
use even after 11 months of storage at 4C. Plaques first be­
came visible under plaquing medium after approximately 30 to 
36 hours of incubation at 37C and were usually counted at 
48 hours post infection. At 72 and especially 96 hours 
post infection these plaques were often enlargpn to such an 
extent that several plaques fused together making it diffi­
cult to count them accurately. Examples of typical virus 
plaques which developed under plaquing medium may be seen 
in Figures 1 and 2. 
Plaque sizes 
The size of plaques produced by H. bovis strains in EBT 
monolayers under plaquing medium was compared. The size of 
25 plaques of each strain using anti-650 serum and again 
using anti-K22 serum was measured and the arithmetic mean was 
Figure 1. Plaques produced by 550 virus (IBR) in EBT cells 
using plaguing medium with 0.5 per cent anti-
650 virus serum (X4.6) 
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FiQuire 2. Flaques produceô ny K-m{ i i n k.bt cells 
using plaguing medium with 0.5 per cent anti-550 
virus serum (X4,6) 
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calculated. The results of these studies are given in Tables 
11 and 12. 
Burst size 
Preliminary studies indicated that the various H. bovis 
strains replicated with varying efficiency in MDBK cells. The 
cells were grown in cell production roller bottles and were 
infected with each H. bovis strain using 10 pfu per cell. 
Virus adsorption was carried out for 2 hours and the virus 
produced was harvested and assayed 48 hours post infection. 
The average amount of virus produced per cell was then calcu­
lated. The results of these experiments are given in Table 
13. 
Neutralization kinetics 
Preliminary studies Preliminary investigations were 
conducted using neutralization kinetics to examine the role 
of complement in the neutralization of H. bovis by specific 
early and late antisera and by purified globulins derived 
from such sera. A preliminary study was also carried out to 
determine the feasibility of using this procedure for 
distinguishing strains of H. bovis. 
The fresh guinea pig serum used as the source of comple­
ment was tested prior to use in neutralization kinetics for 
the presence of nonspecific virus inhibitors. Only sera which 
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Table 11. Plaque size of H. bovis strains using anti-650 
serum 
Virus Average Plaque Size (pm) Range (ym) 
650 733 286-1001 
1309 668 515-858 
K22 433 200-858 
Steiner 589 257-858 
Diamond 602 286-801 
Jensal 635 372-772 
Table 12. Plaque size 
serum 
of H. bovis strains using anti-K22 
Virus Average Plaque Size (ym) Range (ym) 
650 788 515-913 
1309 818 572-1015 
K22 638 358-1073 
Steiner 708 572-858 
Diamond 608 429-787 
Jensal 601 501-715 
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Table 13. Amount of virus produced by H. bovis strains in 
MDBK cells 







were free of such inhibitors were used for neutralization 
kinetics. The results of a test on a serum found to be 
virtually free of such nonspecific inhibitors is presented in 
Figure 5. Guinea pig sera used for neutralization kinetics 
did not significantly affect the titer of H. bovis in the 
presence of normal rabbit serum either (Figure 6). 
Early 19S (IgK), late 19S and early 7S (IgG) required 
complement for the efficient neutralization of H. bovis 
{Figures 7, 8 and 9). In contrast, late 7S efficiently 
neutralized H. bovis in the absence of complement but the 
rate of neutralization was still slightly enhanced by comple­
ment (Figure 10). The neutralization of H. bovis by early 
whole antiserum was complement-dependent (Figure 11) while 
neutralization by late whole antiserum was not complement-
dependent since complement enhanced the neutralization rate 
Figure 3. Neutralization kinetics using 650 virus (IBR) 
and early 650 virus 19S antibodies (IgM). The 
plaques produced by the virus after 0 and 4 
minutes neutralization can be seen (XI.3) 
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Figure 4. Neutralization kinetics using 650 virus (IBR) 
and early 650 virus 19S antibodies (IgM). Note 
the plaques produced after 8 and 12 minutes of 
neutralization (XI.3) 
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Figure 5. Effect of complement (c) on 650 virus. The virus 
titer was not affected significantly by comple­
ment when saline was used instead of antiserum 
in the neutralization kinetics procedure 
Figure 6. Effect of complement (c) on 650 virus. The virus 
titer was not affected significantly by comple­
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2 MINUTES 10 
Figure 7. Neutralization of 650 virus (IBR) by early 
homologous 19S antibodies (IgM). Complement 
(c) significantly increased the neutralization 
rate. Little neutralization occurred in the 
absence of complement 
Figure 8. Neutralization of 650 virus (IBR) by late 
homologous 19S antibodies (IgM). Little neutral­
ization occurred in the absence of complement (c) 
but rapid neutralization was observed in the 
presence of complement 
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Figure 9. Neutralization of 650 virus (IBR) by early 
homologous 7S antibodies (IgG). The virus 
was rapidly neutralized but only in the 
presence of complement (c) 
Figure 10. Neutralization of 650 virus (IBR) by late 
homologous 7S antibodies (IgG). The virus 
was rapidly neutralized in the absence of 
complement (c) but complement did seem to 
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Figure 11. Neutralization of 650 virus (IBR) by early 
homologous whole antiserum. Efficient 
neutralization occurred only in the presence 
of complement (c) 
Figure 12. Neutralization of 650 virus (IBR) by late 
homologous whole antiserum. The virus was 
rapidly neutralized in the absence of 
complement (c) but complement did enhance 
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only slightly with the latter serum (Figure 12). As a re­
sult of these findings complement was routinely included 
in all further neutralization kinetics trials when early 
7S, early 19S and late 19S globulins were used. An example 
of the neutralization kinetics procedure may be seen in 
Figures 3 and 4. 
Experiments were then conducted to determine which 
globulin type possessed the greatest potential for distinguish­
ing strains of H. bovis in the neutralization kinetics pro­
cedure. The neutralization rate of virus 650 (IBR) was simi­
lar to that of virus K22 (IPV) in the presence of early anti-
K22 7S globulin (Figure 13). These two viruses were also 
neutralized at almost an equal rate by anti-650 early 7S 
globulin (Figure 14). In addition, these viruses were also 
indistinguishable by their rates of neutralization when 
tested with late anti-K22 7S globulin or late anti-650 7S 
globulin (Figures 15 and 16 respectively). In contrast, K22 
virus was neutralized at a greater rate than 650 virus was 
by early anti-K22 19S globulin (Figure 17). This difference 
in neutralization rate was even more pronounced when late anti-
K22 19S globulin was used (Figure 18). As a consequence of 
these results late 19S globulins from H. bovis antisera 
were used in all subsequent neutralization kinetics trials 
in which H. bovis strains were compared. 
Figure 13. The neutralization of 650 virus (IBR) and K22 
virus (IPV) by early anti-K22 (anti-IPV) 7S 
globulins (IgG). Both viruses were neutralized 
at a similar rate 
Figure 14. The neutralization of 650 virus (IBR) and K22 
virus (IPV) by early anti-650 (anti-IBR) 7S 
globulins (IgG). Both viruses were neutralized 
at a similar rate 
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2 MINUTES 10 
Figure 15. Neutralization of 650 virus (IBR) and K22 virus 
(IPV) by late anti-K22 (anti-IPV) 7S globulins 
(IgG). Both viruses were neutralized at a 
similar rate 
Figure 16. Neutralization of 650 virus (IBR) and K22 virus 
(IPV) by late anti-650 (anti-IBR) 7S globulins 
(IgG). Both viruses were neutralized at a 
similar rate 
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Figure 17. Neutralization of 650 virus (IBR) and K22 virus 
(IPV) by early anti-K22 (anti-IPV) 19S globulins 
(IgM). The homologous strain (K22) was neutral­
ized somewhat more rapidly than the heterologous 
strain (650) 
Figure 18. Neutralization of 650 virus (IBR) and K22 virus 
(IPV) by late anti-K22 (anti-IPV) 19S globulins 
(IgM). The homologous strain (K22) was 
neutralized more rapidly than the heterologous 
strain (650) 
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Comparative studies The rates of neutralization of 
the H. bovis strains by late anti-K22 19S globulins are 
given in Figure 19 in graphical form. The data from which 
these graphs were plotted are given in Table 14. The 
neutralization rate constants and normalized neutralization 
rate constants of these viruses are listed in Table 15. 
Linear regression and Student T test data representing the 
neutralization of H. bovis by K22 virus 19S antibodies are 
presented in Table 16. 
A 1:2 dilution of late anti-K22 19S globulin was found 
in preliminary tests to be the most suitable dilution for use 
in these neutralization kinetics trials. The globulin con­
centration was considered suitable when 90-95 per cent of 
the homologous virus was neutralized within 15 minutes. 
The rate at which late anti-650 19S globulins neutralized 
tJ cr4--vr»TT>c? ic? 4 v* nr* T? 4 OO 
The data from which these graphs were plotted are presented 
in Table 17. The K and NK values representing neutralization 
by this globulin preparation are listed in Table 18. Linear 
regression and Student T test data representing the neutraliza­
tion of H. bovis by 650 virus 19S antibodies are presented in 
Table 19. A 1:4 dilution of late anti-650 19S globulins was 
used in these trials since preliminary work indicated that at 
Figure 19. Neutralization of H. bovis strains by late anti-
K22 (anti-IPV) 19S globulins (IgM). The 2 
vaccine strains (Jensal and Diamond) were 
neutralized at a similar rate, while the 2 
respiratory strains (1309 and 650) and one 
genital strain (Steiner) were neutralized at a 
similar rare. The other genital strain (K22) 
was neutralized more rapidly than the 
respiratory strains, but slower than the 
vaccine strains 
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Table 14. Neutralization kinetics data of H. bovis strains 
with late anti-K22 19S globulins 
Virus Time (min) Rssay^l" Assay 2 
K22 0 91 76 
5 37 46 
10 21 18 
15 10 6 
Steiner 0 90 94 
5 70 69 
10 38 35 
15 30 26 
650 0 72 74 
5 50 44 
10 34 25 
15 16 17 




5 54 56 
10 33 36 
Jensal 0 97 98 
5 9 17 
10 1 0 
15 0 1 
Diamond 0 ' 69 72 
5 6 4 
10 2 0 
15 2 0 
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Table 15. Neutralization rate constants (K) and normalized 
neutralization rate constants (NK) of H. bovis 
strains with late anti-K22 19S globulins 
Virus K NK 
K22 0.080 100.0 
Steiner 0.041 51.3 
650 0.049 61.3 
1309 0.045 56.3 
Jensal 0.222 277.5 
Diamond 0.265 331.5 
this dilution 90 to 95 per cent of the homologous virus was 
neutralized in 15 minutes. 
The indirect fluorescent antibody test (FAT) 
Nonspecific staining In the FAT, conjugates directed 
either against rabbit 19S or 7S globulins were prepared from 
7S globulins purified by gel filtration from chicken anti-
sera. Nonspecific staining was encountered with both these 
conjugates in the control preparations which consisted of un­
infected cells treated with specific antisera or globulin 
fractions of these sera and infected cells exposed to normal 
rabbit serum. The nonspecific staining was virtually 
eliminated by DEAE cellulose chromatography of the conjugates 
and by absorbing the antisera or globulin fractions with 
EBT cells. 
A 0.3 M,pH 6-8 equilibration buffer was superior to a 0.1 
Table 16. Statistical analysis of 
late anti-K22 virus 19S 
the neutralization 
globulins 
o;f H. bovis strains by 
Virus B valued Standard Tested deviation against T value^ P<0.05^ 
K22 —0.0652 0.0045 650 4.452 Yes 
Steiner -0.0359 0.0029 650 1.39 No 
650 -0.0416 0.0028 Steiner 1.39 No 
1309 -0.0379 0.0021 650 2.179 No 
Diamond -0.1076 0.0234 Jensal 0.75 No 
Jensal -0.1301 0.0202 Diamond 0.75 No 
^Estimate of t:he linear regression coefficient. 
^The difference of the B values divided by the pooled standard deviation 
of the viruses tested. 
"^Neutralization slopes differ at the 95 per cent confidence level. 
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Table 17. Neutralization kinetics data of H. bovis strains 
with late anti-650 19S globulins 
Virus Time Imin) ^say^l" "Lsay 2 
K22 0 99 104 
5 19 21 
10 7 6 
15 12
Steiner 0 90 97 
5 23 26 
10 5 5 
" 1 5  0  2  
650 0 83 80 
5 35 31 
10 15 11 




1309 0 60 64 
5 25 22 
10 9 9 








5 4 4 
1 0  G O  
15 10 
Jensal 0 77 83 
5 3 5 
" 10 0 0 
15 10
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Table 18. Neutralization rate constants (K) and normalized 
neutralization rate constants of H. bovis strains 
with late anti-650 19S globulins 
Virus K NK 
K22 0.078 169.6 
Steiner 0.069 150 
650 0.046 100 
1309 0.047 102.2 
Jensal 0.149 323.9 
Diamond 0.156 339.1 
M, pH 6.8 buffer in the DEAE cellulose chromatography pro­
cedure since with the latter, specific fluorescence was re­
duced along with nonspecific staining. In subsequent experi­
ments all the chicken 7S globulin conjugates were subjected 
to DEA2 cellulose chromatography using a 0.3, pK 6.S 
equilibration buffer, absorbed with EBT cells and filtered 
through a 220 nm membrane filter= Antisera and globulin 
fractions derived from such antisera were also absorbed with 
EBT cells before use in the FAT. 
Autofluorescence In initial trials using the number 
50 barrier filter provided on the microscope, considerable 
greenish autofluorescence was encountered in the specimens. 
However, this problem was effectively eliminated by changing 
Table 19. Statistical analysis of the neutralization of H. bovis strains by 
anti-650 virus 195 globulins 




against T value^ P< 0.05^ 
K22 -0. 1062 0. , 0056 Steiner 1 . 66 No 
Steiner -0. 1167 0. 0089 K22 1, .66 No 
650 -0. 0747 0. ,0046 K22 14. 78 Yes 
1309 -0. 0714 0. ,0034 650 0. 579 No 
Diamond -0. 1225 0. ,0264 Jensal 0. .09 No 
Jensal -0. ,1193 0. , 0259 Diamond 0. .09 No 
^Estimate of the linear regression coefficient. 
^The difference of the B values divided by the pooled standard deviation 
of the viruses tested. 
^Neutralization slopes diffei at the 95 per cent confidence level. 
Figure 20. Neutralization of H. bovis strains by late 
anti-650 (anti-IBR) 198 globulins (IgM). 
Note that the genital strains (K22 and 
Steiner) were neutralized more rapidly than 
the respiratory strains (650 and 1309). The 
vaccine strains (Diamond and Jensal), however, 
were neutralized more rapidly than the genital 
strains 
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the barrier filter to number 53 which changed autofluorescence 
to a dull yellow. 
Conjugate and antiserum concentrations Serial 2-fold 
dilutions of rabbit globulin preparations and FITC conjugates 
were made in 0.01 M, pH 7.5 PBS. The FAT was carried out 
using slide preparations of the homologous virus so that 
every conjugate dilution was tested with every globulin 
dilution= The maximum globulin and conjugate dilutions which 
still gave bright fluorescence in the homologous system were 
determined. These preparations were used at their maximum 
dilutions in subsequent comparison trials. The maximum dilu­
tion of the anti-rabbit 7S conjugate was 1:5 to 1:10 while 
for anti-19S it was 1:2 to 1:4. The maximum dilution of late 
rabbit 19S globulins was 1:4 to 1:8. The maximum dilution of 
late rabbit 7S globulins was not determined, but bright 
fluorescence was observed with this fraction even at a 1:20 
dilution which was the concentration used in these trials. 
Cross reactions between anti-rabbit 19S and anti-rabbit 
7S globulins Virus preparations treated with rabbit anti-
H. bovis 19S globulins fluoresced only very faintly when the 
anti-rabbit 7S globulin-FITC conjugate was used but bright 
fluorescence resulted with the anti-rabbit 19S-FITC conjugate. 
This fluorescence seemed to occur primarily on the surfaces 
of cells (Figure 21). However, virus preparations treated 
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with specific rabbit anti-H. bovis IS globulins fluoresced 
with both the anti-rabbit 19S and the anti-rabbit 7S globulin-
FITC conjugates. This fluorescence was observed in the entire 
cytoplasm of the cells (Figure 22). 
Comparison trails Late rabbit anti-H. bovis 19S 
globulins diluted 1:4 and FITC-labeled anti-rabbit 19S 
globulin conjugate diluted 1:2 were used for comparing 
H. bovis strains. Preliminary trials with anti-650 19S 
globulins resulted in similar fluorescence with all the 
H. bovis strains (Table 20). The specificity of both 7S 
and 19S anti-650 rabbit globulin preparations for H. bovis 
can be seen in Table 20 since no fluorescence was observed 
in H. bovis preparations treated with anti-DN599 virus 
globulins. 
In an attempt to narrow the specificity of the FAT, 
anti-K22 virus rabbit 19S globulins were absorbed with 650 
virus-infected MDBK cells while anti-650 virus rabbit 19S 
globulins were absorbed with K22-virus-infected MDBK cells. 
The results of the FAT tests with virus-absorbed conjugates 
are listed in Tables 21 and 22. 
Figure 21. The FAT with Diamond-virus-infected EBT cells 
treated with anti-K22 virus 19S globulins and 
anti-19S FITC conjugate. Many intensely 
fluorescing cells can be seen. Fluorescence 
on the surface of the cells may be seen on 
some of the cytoplasmic processes (XlOOO) 
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Figure 22. The FAT with Jensal-virus-infected EST cells 
treated with anti-650 virus 7S globulins and 
c i i i C x - 1 o  r x x v -  c o i i j a y a L e .  w o u t ;  L i i e  p r e ­
dominantly cytoplasmic fluorescence (XlOOO) 
138 
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Table 20. The FAT with anti-650 rabbit globulins 
preparation Conjugate Fluorescence 
K22 19S; anti 650 anti 19S + 
Steiner M II + 
650 II II + 
1309 II 11 + 
Diamond It II + 
Jensal II n + 
K22 7S; anti 650 anti IS + 
650 7S; anti 650 II + 
K22 7S; anti DM599 It — 
650 II II -
K22 19S; anti DN599 anti 19S -
Table 21. The FAT with H. bovis strains treated with 650-
virus-absorbed anti-K22 virus 19S globulins and 
anti-rabbit 19S FITC conjugate 
Nonabsorbed 19S Virus absorbed 19S 
globulin globulin 
K22 4+^ 1+ 
Steiner 4 + 2+ 
650 4+ 1-2+ 
1309 4+ 2+ 
m ^ 4+ 1-2+ 
Jensal 4+ 1-2+ 
^The intensity of fluorescence was rated subjectively on 
a scale of 1+ through 4+. 
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Table 22. The FAT with H. bovis strains treated with K22-
virus-absorbed anti-650 virus 19S globulins 
and anti-rabbit 19S FITC 
Virus Nonabsorbed 19S 
globulin 





















Preliminary experiments Some of the parameters of 
the lEOP test as it applied to H. bovis were developed in 
preliminary experiments. A nonspecific faint precipitin line 
developed between H. bovis antigens and undiluted late specific 
antisera or late anti-DN599 sera. This band disappeared after 
absorption of the antisera with MDBK cells. At least two 
virus-specific antigens were detectable by this test using 
late II. boVi3 iiTauune ssra^ but no apparent reaction occurrcd 
with early immune sera. 
Several dilutions of antigen and antiserum were used in 
the test to determine whether these reagents possessed adequate 
potency for the lEOP test. The maximum dilutions of antigen 
(1:4) and antiserum (1:32) used in preliminary tests resulted 
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in the same number of precipitin lines as with undiluted 
preparations, but they were somewhat fainter staining. The 
distance between antigen and antiserum wells was important 
since bands developed between wells 6 mm apart but not between 
wells 16 mm apart. 
Comparison trials Purified globulin preparations 
previously absorbed with MDBK cells were used in the lEOP 
test for comparing H. bovis strains, Anti-K22 virus-19S, 
anti-650 virus 19S, anti-K22 virus IS, and anti-650-7S globu­
lins derived from late immune sera were used in the test. In 
addition, 650-virus-absorbed anti-K22 virus globulins and K22 
virus-absorbed anti-650 virus globulins were included in the 
test in an attempt to narrow the specificity of these prepara­
tions. 
The H. bovis antigen preparations were used undiluted in 
the test. The 19S globulins were not diluted for the test 
while several dilutions of the 7S globulins were used. The re­
sults of lEOP trials with the various H. bovis antigens are 
given in Tables 23 through 29. Typical positive virus-
specific reactions are illustrated in Figure 23. 
Radial immunodiffusion (RID) test 
Initially, the reverse RID test was used in which virus 
partially purified by differential centrifugation was in­
corporated into the agarose layer on a glass slide and antisera 
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Table 23. The lEOP test with K22 virus 
Globulin preparation C^?bulin Distinct 
dilution bands 
19S; anti-K22 Undiluted 0 
19S; 650-absorbed anti-K22 " 0 
19S; anti-650 " 0 
19S; K22-absorbed anti-650 " 0 
7S; anti-650 Undiluted 2 
" 1:5 2 
" 1:10 1 
" " 1:20 1 
1:40 1 
7S; K22-ab£crDed anti-650 Undiluted 0 
" 1:5 0 
" 1:10 0 
" " 1:20 0 
7S; anti-K22 Undiluted 1 
" 1:5 1 
" 1:10 1 
" " 1:20 0 
" " 1:40 0 
7S; 650-absorbed anti-K22 Undiluted 1 
" " 1:5 1 
" 1:10 0 
" 1:20 0 
were placed in wells in this layer. Various concentrations 
of virus (lo'^, 2X10^, 4X10^ and 10^ pfu per ml of agarose) 
were used but its incorporation imparted a turbidity to the 
agarose layer making it difficult to observe precipitin 
reactions. A positive reaction consisting of two precipitin 
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Table 24. The lEOP test with Steiner virus 




19S; 650-absorbed anti-K22 
19S; anti-650 





7S; anti-650 Undiluted 2 
" 1:5 2 
" 1:10 2 
" " 1:20 1 
1:40 1 
7S; K22-absorbed anti-650 Undiluted 0 
" 1:5 0 
" 1:10 0 
" " 1:20 0 






7S; 650-absorbed anti-K22 Undiluted 1 
" 1:5 1 
" 1:10 1 
" " 1:20 0 
rings was observed only at the highest concentration of virus 
used. The reverse RID test was thus discontinued because of 
its relative insensitivity and the difficulty encountered in 
observing positive reactions. 
The standard RID procedure in which antisera were incor­
porated into the agarose layer proved to be more sensitive and 
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Table 25. The lEOP test with 650 virus 




19S; 650-absorbed anti-K22 
19S; anti-650 
















































produced considerably clearer agarose layers than the re­
verse RID procedure. 
The standard RID test with agarose layers containing 
various dilutions of IS globulins derived from H. bovis anti-
sera was used for comparing H. bovis strains by RID. In 
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Table 26. The lEOP test with 1309 virus 





19S; 650-absorbed anti-K22 
19S; anti-650 















































addition 1309-virus-absorbed anti-K22 7S globulins and 
Steiner-virus-absorbed anti-650 7S globulins were also used 
in an attempt to narrow the specificity of the RID test. All 
globulin preparations were absorbed with MDBK cells prior to 
their use in the test. 
The diameter of precipitin rings decreased as the 
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Table 27. The lEOP test with Diamond virus 





19S; 650-absorbed anti-K22 
19S; anti-650 




















































globulin concentration in the agarose layer decreased. Some 
precipitation zones were fainter at higher antiserum concen­
trations than at lower concentrations while others became 
fainter as the antiserum concentration in the gel decreased. 
The results of the RID test with H. bovis strains are given 
in Tables 30 through 37. An example of the RID test with 
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Table 28. The lEOP test with Jensal virus 
Globulin preparation Globulin Distinct 
dilution bands 
19S; anti-K22 Undiluted 0 
19S; 650-absorbed anti-K22 " 0 
19S; anti-650 " 0 
19S; K22-absorbed anti-650 " 0 
IS; anti-650 Undiluted 2 
" 1:5 3 
" 1:10 3 
" 1:20 2 
" 1:40 0 
7S; K22-absorbed anti-650 Undiluted 0 
1:5 1 
" " 1:10 1 
1:20 0 
7S; anti-K22 Undiluted 1 
" 1:5 2 
" 1:10 2 
" 1:20 0 
1:40 0 
7S; 650-absorbed anti-K22 Undiluted 1 
" 1:5 2 
" 1:10 1 
" 1:20 0 
Table 29. Summary of lEOP with H. bovis strains 
Maximum number of bands observed 
type K22 Steiner 650 1309 Diamond Jensal 
7S; anti-650 2 2 2 3 3 3 
7S; K22-cibsorbed anti-650 0 0 0 1 1 1 
7S; anti-K22 1 1 1 2 2 2 
7S; 650-absorbed anti-K22 1 1 1 1 1 1 
Figure 23. The lEOP test with Jensal virus. Virus antigen 
was applied to the lower row of wells while 
immunoglobulins were placed in the upper row of 
wells. The right hand immunoglobulin well 
received anti-650 virus 19S globulin while the 
other three wells received ?nti-6?0 "S ginhniin 
diluted 1:20, 1:10, and 1:5 from left to right, 
respectively. No precipitin bands were ob­
served with the 19S globulin preparation while 3 
bands were observed between the virus antigen 
and 7S globulin wells. Stained with Coomassie 
Brilliant Blue (X3) 
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7S; anti-K22 80 8.5 3.5 2 
40 — 3.5; 4.5 2 
20 - 4.2; 6.0 2 
--
10 4.2; 6.5 — 2 
7S; 1309—absorbed anti—K22 - 80 3 . 5 — 1 
I I  40 3.2 - 1 
I I  20 4.0^ - 1 
- -
10 — — 0 
7S; anti-650 80 10.0^ 3.5; 4.5 3 
40 11. 0 3.8; 5.0 3 
3. 20 - 4.2; 6.0 2 
]. 10 - 7.5; 5.1; 3.9 3 
7S; Steiner-absorbed anti-650 1: 80 — 4.0; 6.0 2 
]- 40 7.0^ 3.5; 4.2 3 
1; 20 4.0 5.5 2 
1: 10 4.5; 7.0 - 2 
^Very faint ring of precipitation. 













7S; anti-K22 1:H0 8 . 0 3.8 2 
1:40 - 3.5; 4.2 2 
1:20 - 4.5; 5.5 2 
1:10 — 5.0; 7.0 2 
7S; 1309-absorbed anti-K22 1:80 3.5 — 1 
1:40 3.7 - 1 
1:20 4.0 - 1 
1:10 — — 0 
7S; anti-650 1:80 7.5® 3.6; 5.0 3 
f l  I I  1:40 8.5 3.8; 5.1 3 
I I  I I  1:20 - 4.2; 6.7 2 
I I  1:10 — 3.6; 5.5; 9.5 3 
7S; Steiner-absorbed anti-650 1:13 0 — 4.0; 7.0 2 
1 1  r i  1:40 - 3.5; 4.6 2 
t l  I I  1:20 4.0 5.4 2 
n 1:10 4.5; 6.5 - 2 
^Very faint ring of precipitation. 













75; anti-K22 1:30 6.0 3.5 2 
I I  t l  1:40 - 3.7 1 
I I  I I  1:20 - 4.5 1 
11 I t  1:10 4.0 - 1 
7S; 1309-absorbed anti-K22 1: 80 3.0 — 1 
I I  11 1:40 3.5^ - 1 
I I  I f  1: 20 3.0 - 1 
1:10 — — 0 
7S; anti-650 1:30 7.5 3.6 2 
1:40 8.0 3.5 2 
1:20 - 4 . 0 1 
1:10 — 4.0; 4.5 2 
7S; Steiner-absorbed anti-650 1:80 — 3.5 1 
1:40 - 4.0 1 
1:20 - 4.1 1 
1:10 5.0 — 1 
^Very faint ring of precipitation. 













7S; anti-K22 1:80 6.0 3.5; 4.5 3 
1 9  I I  1:40 - 4.1; 6.0 2 
t9 r r  1:20 - 4.9; 8.0 2 
1:10 6 . 0 — 1 
7S; 1309-absorbed anti-K22 1:80 4.0 — 1 
I I  1:40 4.1_ - 1 
I I  1:20 5.0 - 1 
1:10 — — 0 
7S; anti-650 1:80 14.0^ 3.5; 4.6 3 
1 1  1:40 16.0 4.0; 5.0 3 
ri 1:20 - 4.1; 6.0 2 
I I  1:10 — 5.0; 8.0 2 
7S; Steiner-absorbed anti-650 1:80 — 3.5; 4.8 2 
1:40 - 4.0; 6.0 2 
I I  1:20 4.1 7.7 2 
I I  1:10 5.0; 10. 0 2 
^Very faint ring of precipitation. 













7S; anti-K22 1:80 5.5 4.0 2 
I I  1:40 - 3.3; 4.1 2 
I I  1:20 — 4.2; 5.8 2 
I t  1:10 5.0 — 1 
7S; 1309-absorbed aati-K22 1:80 3.5 — 1 
1:40 4 . 1 a  - 1 
I I  1:20 5.0* - 1 
t l  1:10 — — 0 
7S; anti-650 1:80 7.5* 3.7 2 
I I  1:40 10.0 3.8 2 
t l  I I  1:20 - 4.1 1 
n 1:10 - 4.5; 5.0 2 
7S; Steiner-absorbed anti-650 1:80 — 3.5 1 
1:40 - 4.0; 4.2 2 
" 1:20 4.1_ 5.0 2 
1:10 5.0 6.5 2 
^Very faint ring of precipitation. 





Diameter of Diameter of 
faint rings distinct 
(mm) rings (mm) 
Total 
rings 
7S; anti-K22 1:80 5.5 3.0; 4.2 3 
I I  1:40 - 4.0; 5.5 2 
1 1  1:20 — 4.5; 7.2 2 
I I  1:10 5. 5; 8.0^ — 2 
7S; 1309-absorbed anti-K22 ]. : 80 4.0 — 1 
I I  1:40 4.0 - 1 
I I  1:20 5.0 - 1 
I I  1:10 — — 0 
7S; anti-650 1:80 16.0^ 3.5; 4.1 3 
I t  1:40 20.0 3.5; 4.2 3 
I I  1:20 - 4.0; 5.1 2 
I I  1:10 — 4.2; 7.0 2 
7S; Steiner-absorbed anti-650 1:80 _ 3.5; 4.25 2 
1:40 - 4.0; 5.0 2 
I I  I I  1:20 4.0 6.5 2 
I I  I I  1:10 5. 0; 9.0 - 2 
^Very faint ring of precipitation. 
Table 36. Summary of the RID test with H. bovis strains 
Globulin type Maximum number of rings observed K22 Steiner 650 1309 Diamond Jensal 
7S; anti-K22 2 2 2 3 3 3 
7S; 1309-absorbed anti-K22 1 1 1 ]. 1 1 
7S; anti-650 3 3 3 3 3 3 
78; Steiner-absorbed anti-650 3* 2 1 2 2 2 
^One band was very faint. 
Table 37. Diameter of the largest distinct precipitin ring: in the RID test 
with H. bovis strains 
Size of precipitin rings (mm) 
K22 Steiner 650 1309 Diamond Jensal 
7S; anti-K22 6.0 5.5 4.5 8.0 5.8 7.2 
7S; anti-650 7.5 9.5 4.5 8.0 5.0 7.0 
Figure 24. The RID test with H. bovis strain antigens. 
Note the difference in size of the precipitin 
rings. Also note the double zone around the 
two outside wells. In addition, 2 large faint 
precipitin rings may be observed around the 




H. bovis antigens is presented in Figure 24. No extra 
precipitin rings were observed after RID preparations were 
stained with Coomassie Brilliant Blue. 
The DN599, FTCl, and Vll Virus Group 
Plaguing procedure 
Since considerable difficulty was initially encountered 
in the assay of DN599, FTCl, and Vll viruses, an attempt was 
made to establish methods which would enhance plaque produc­
tion by these viruses in cell cultures. 
Agar overlay Plaques developed in cell monolayers 
after 10 to 12 days incubation when an agar-BME-FCS overlay 
was used. Madin Darby bovine kidney cells were unsuitable 
for plaque production by these viruses since the cells usually 
degenerated 7 to 8 days after seeding. Embryonic bovine 
trachea cells were used in assay procedures for these viruses 
since these cells remained viable well beyond the 10 to 12 
days required for plaque development. In addition, a more 
uniform monolayer developed with EBT cells than with MDBK 
cells which grew very densely in the center of Linbro plate 
wells which frequently made it difficult to observe plaques in 
the periphery of the wells. The plaques which developed in 
cells under an agar overlay were indistinct and very small 
(usually less than 300 ym in diameter) even after 12 days of 
incubation. 
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Protamine and DEAE dextran supplementation The in­
fluence of DEAE dextran and protamine supplementation of agar 
overlays on plaque production by FTCl virus is listed in 
Table 38. In this experiment 10 days of incubation post in­
fection were allowed after which the cells were fixed, stained, 
and the average size of 25 plaques was determined. Protamine, 
at a concentration of 100 yg per ml of overlay, markedly en­
hanced plaque formation by FTCl virus, but the presence of 
DEAE dextran in the overlay prevented plaque formation. The 
presence of DEAE dextran in the virus diluent or protamine in 
the agar overlay did not significantly increase virus titer. 
Protamine supplementation of agar overlay also increased the 
size of plaques produced by DN599 and Vll viruses. 
Methyl cellulose and agarose overlays The influence 
of various overlays on plaque production by FTCl virus in EBT 
cell cultures was investigated. The overlays compared in this 
study were prepared in BME and contained 2 per cent methyl 
cellulose (15 centipoises), 2 per cent methyl cellulose 
(4,000 centipoises), 0.6 per cent agarose, or 0.6 per cent 
Noble agar. Each of these overlays was supplemented with 
protamine to a concentration of 100 ug per ml. 
The cells in this experiment were fixed and stained 10 
days post infection. The plaques which developed under both 
the methyl cellulose overlays were extremely small and 
difficult to see. No plaques were observed with the agarose 














- - - 343 143-644 3.5X10^ 
+ 
-
- 343 157-644 6.2X10^ 
+ + - Indistinct -
+ + 4- No plaques -
+ - + 829 286-2431 7X10^ 
+ 844 358-2431 6.6X10^ 
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overlay since the cells rapidly degenerated when this overlay 
was used. The plaques under the Noble agar overlay were 
distinct but had an irregular outline and a marked variation 
in size. A virus titer of 2.3X10^ pfu per ml could be demon­
strated using the agar overlay method. 
In a further experiment the protamine level in the 
various overlays was reduced to 25 yg per ml as recommended 
by Wallis and Melnick (284) . In this experiment the results 
were identical to the previous trial in which the overlays 
contained 100 yg per ml of protamine. 
Virus assay in freshly seeded cells A virus assay 
procedure was developed in which cells, freshly seeded in 
Linbro plate wells, were infected with the virus suspended 
in growth mediuin. An agar overlay supplemented with 100 yg 
protamine per ml was placed on Lhe cells 24 hours after in­
fection. Plaques were clearly visible 5 to 6 days post in­
fection and were more distinct than with any method previously 
used (see Figures 25 and 26). A titer of 3.1X10^ pfu per ml 
was demonstrated with DN599 virus on the first trial using 
this method. A linear relationship was observed between 
virus concentration and the number of plaques which developed. 
An experiment was conducted to determine the effect of 
varying the time interval between cell infection and place­
ment of the overlay on the infected cells. A protamine-
Figure 25. Plaques produced by DN599 virus in EBT cells. 
Note the irregular shape and size of the 




Figure 26. Plaques produced by FTCl virus in EBT cells. 




supplemented agar overlay was placed on DN599 virus-infected 
EBT cells in each of three wells 24, 48, 72 and 96 hours 
after the simultaneous seeding and infection of the cells. 
At 6 days post infection the average number of plaques 
per well for each interval was 42, 44, 49 and 56, respectively. 
Serum supplementation The effect of supplementing the 
agar-BME-protamine overlay with sera of different animal 
species was investigated. The plaques which developed in 
DN599-infected EBT cells under an overlay supplemented with 
10 per cent rabbit serum were more distinct than when the same 
concentration of PCS or sheep serum was used. The average 
number of plaques observed in 3 Linbro plate wells containing 
the rabbit-serum-supplemented overlay on EBT cells infected 
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with a 10 dilution of DN599 virus was 113 pfu per well com­
pared to 83 and 74 pfu per well when PCS and sheep serum, 
respectively, v/ere used in overlays placed on similarly in­
fected cells. 
Plaque development with specific antisera The possi­
bility of using specific antiserum in liquid medium for plaque 
production by DN599 virus in EBT cells was investigated. A 
10 ^ dilution of DN599 virus in growth medium was used to in­
fect freshly seeded EBT cells in Linbro plate wells. MEM 
medium supplemented with 10 per cent PCS and 10, 5, 2.5, 1.25, 
0.65 and 0.25 per cent concentrations of specific antiserum 
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was placed in each of 3 wells containing virus-infected cells. 
Protamine at a final concentration of 100 yg per ml was added 
to one well at each antiserum concentration. The cells were 
fixed and stained 6 days post infection, but the plaques in 
all the wells were very indistinct. 
Neutralization kinetics 
Kinetic neutralization was carried out with FTCl, DN599, 
and Vll viruses as described in "Materials and Methods". 
Growth medium was used as a diluent in this test since the 
virus plaque assay was carried out by the method of infecting 
freshly seeded cells as described above. A Noble agar-BME-
FCS-protamine overlay was placed on these cells 24 hours post 
infection. 
Specific anti-DN599 rabbit serum, with a 50 per cent 
plaque reduction titer of 1:120 was used at a dilution of 1:10 
in the neutralization kinetics procedure. 
As can be seen in Figure 27 and Table 39, the neutraliza­
tion of these viruses was exceptionally slow. Even after 3 
hours of exposure to the antiserum, a substantial fraction (14 
to 16 per cent) of each virus remained infectious. The log 
virus titer versus time relationship was relatively linear for 
the first 45 minutes with DN599 and for 75 minutes with FTCl 
virus and Vll virus after which it became quite irregular (see 
Figure 27). DN599 virus was stable at 37C since in the presence 
Figure 27. Neutralization kinetics with DN599, FTCl, and Vll 
viruses using anti-DN599 rabbit serum. Initially 
the neutralization rate was linear but became 
very irregular. Note the prolonged period 
required to neutralize these viruses 
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Table 39. Neutralization kinetics of DN599, FTCl, and Vll 
viruses with DN599 antiserum 
Virus Antiserum Average number of plaques 
0^ 15 30 45 75 105 135 180 
DN599 NRS^ 169 _c - 161 - - 162 154 
DN599 DN599 200 136 Ill 81 81 76 29 32 
FTCl DN599 85 71 57 42 21 12 12 13 
Vll DN599 50 45 — 25 19 18 9 7 
"Neutralization time in minutes. 
^Normal rabbit serum. 
Virus assay not done. 
of normal rabbit serum there was virtually no reduction in 
virus titer even after 3 hours (see Figure 27). 
A neutralization kinetics trial was then carried out to 
determine the influence of complement on the neutralization ot 
DN599 virus by specific antiserum. Complement did not, how­
ever, enhance the rate at which this virus was neutralized. 
Reciprocal neutralization tests 
Since it was established that DN599, FTCl, and Vll 
viruses were neutralized very slowly, virus-antiserum mixtures 
were incubated overnight at 4C in the reciprocal neutraliza­
tion procedure. One ml of various antiserum dilutions were 
incubated with one ml of a virus preparation containing ap­
proximately 200 pfu per ml. The residual virus in these 
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mixtures was assayed by the method of infecting freshly seeded 
EBT cells in Linbro plate wells as described in "Materials and 
Methods". An agar overlay supplemented with protamine was 
placed on the cells 24 hours post-infection and the cells were 
fixed, stained, and examined 5 to 7 days later. The dilution 
of antiserum resulting in an approximate 50 per cent re­
duction of plaques was regarded as the serum end point. All 
sera used in this test were previously absorbed with EBT 
cells. In preliminary trials with DN599 virus, its homologous 
serum had a titer of 1:120. This antiserum diluted 1:10 al­
most completely inhibited plaque production by 10 ^ dilu­
tions of Vll and FTCl viruses which in the presence of normal 
rabbit serum produced 73 and 144 plaques, respectively. 
However, serum harvested one month later from the rabbit 
which had yielded the Annve serum, nan a titer of 1:5. 1:5. 
and 1:4 0 when tested with DN599, Vll, and FTCl viruses, 
respectively (see Table 40). 
The results of a reciprocal neutralization experiment 
which included the three above mentioned viruses and their 
antisera are given in Table 40. The DN599 virus antiserum 
used in this trial was collected from the hyperimmunized 
rabbit 5 weeks after the final inoculation since the supply 
of serum taken 10 days after the booster inoculation had been 
exhausted. Serial 2-fold antiserum dilutions of 1:5 through 
1:80 were used in this experiment. 
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Table 40. Reciprocal virus neutralization with DN599, FTCl, 
and Vll viruses 
Virus Antiserum Antiserum titer 
DN599 DN599 1:5 
I I  FTCl >1:80 
I I  Vll 1:20 
FTCl DN599 1:40 
I I  FTCl >1:80 
I I  Vll 1:20 
Vll DN599 1:5 
I I  FTCl 1:80 
I I  Vll 1:20 
Indirect fluorescent antibody test (FAT) 
The FAT was used to investigate the relationship of Vll, 
DN599, and FTCl viruses using 19S globulins (diluted 1:2) and 
7S globulins (diluted 1:6) prepared from specific antisera. 
All the globulin preparations were absorbed with EBT cells 
prior to use in the test. The results of this test are given 
in Table 41. These viruses could not be distinguished from 
one another by the FAT. Fluorescence was observed mainly on 
cell surfaces when 19S globulins were used (Figure 28) while 
with 7S globulins dense perinuclear and granular cytoplasmic 
fluorescence was seen (Figure 29). 
174 
Table 41. The FAT with DN599, FTCl and Vll viruses 
Virus Globulin type Conjugate Fluorescence 
DN599 7S; anti-IBR Anti-7S -
II 19S; anti-IBR Anti-19S -
II 7S; anti-DN599 Anti-7S + 
I I  7S; anti-FTCl I I  + 
I I  7S; anti-Vll I I  + 
I I  19S; anti-DN599 Anti-19S + 
I I  19S; anti-FTC I I  + 
11 19S; anti-Vll I I  + 
FTCl 7S; anti-DN599 Anti-7S + 
I I  7S; anti-FTCl I I  + 
I I  7S; anti-Vll I I  
I I  19S; anti-DN599 Anti-19S + 
I I  19S; anti-FTCl I I  + 
I I  19S; anti-Vll I I  + 
Vll 7S; anti-DN599 Anti-7S + 
I I  73/ âriti"FTCl I I  1 
I I  7S; anti-Vll i l  + 
I I  19S; anti-DN599 Anti-19S + 
I I  19S; anti-FTCl I I  + 
I I  19S; anti-Vll 11  + 
Figure 28. The FAT of FTCl-virus-infected EBT cells treated 
with anti-FTCl 19S globulins and anti-19S-FITC 
conjugate. Note the patchy fluorescence mainly 
in the cell membranes (XIOOO) 
9Z.T 
Figure 29. The FAT of FITOvirus-infected EBT cells treated 
with anti-FTCl IS globulins and anti-7S globulin-
FITC conjugate. Note the predominantly cyto­
plasmic fluorescence (aIOOG} 
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Relationship of H. bovis to the 
DN599-FTC1-V11 Virus Group 
Cytopathic effect (CPE) 
DN599, FTCl and Vll viruses could not be distinguished 
from one another by their growth characteristics in either 
MDBK cells or EBT cells. Growth of these viruses in cell 
cultures was characterized by a slow development of CPE. 
These viruses caused rounding of infected cells which first 
became visible 4 days post infection and a further 2 to 3 days 
usually elapsed before all the cells of a monolayer became 
involved. This CPE developed approximately 2 days earlier 
when freshly seeded cells were infected with these viruses. 
Plaques produced by these viruses required 5 to 10 days to 
develop, had an irregular shape and varied considerably in 
size. In aoni ri onpj pques were not produced by these 
viruses in cells covered with a liquid medium containing 
specific antiserum. 
In contrast, the CPE produced by H. bovis developed in 
infected cell cultures in less than 24 hours post infection. 
Plaques produced by H. bovis were uniform in size, circular, 
and developed within 48 hours. Herpesvirus bovis plaques 
developed readily in cell cultures covered with an antiserum-
containing liquid medium. 
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Serum-virus neutralization 
Neutralization kinetics experiments were carried out to 
investigate a possible serological relationship between H. 
bovis and the DN599 virus group. There was no significant 
neutralization of H. bovis by DN599, FTCl, and Vll virus 
antisera (Table 42) nor were DN599, FTCl, and Vll viruses 
neutralized by anti-H. bovis serum (Table 43). 
Fluorescent antibody test 
Cross reactions between H. bovis and the DN599 virus group 
did not occur with the FAT (see Table 44). 
Table 42. Neutralization of K22-virus (IPV) by DN599, FTCl, 
and Vll antisera 
Antiserum^ Neutralization time (min) 
Surviving virus 
(pfu/ml) 
Anti-DN599 0 48 
If 8 _b 
(t 16 44 
Anti-Vll 0 57 
11 8 52 
ii 16 42 
Anti-FTCl 0 65 
II 8 61 
II 16 59 
^Antisera were used at a 1:10 dilution. 
^Assay was not done. 
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Table 43. Neutralization of DN599, FTCl, and Vll viruses by 
anti-K22 (IPV) serum^ 
Neutralization time Surviving virus 
(min) (pfu/ml) 
FTC 0 143 
I I  15 119 
I t  30 135 
Vll 0 194 
t l  15 
_b 
I I  30 215 
DN599 0 236 
I I  15 244 
I I  30 256 
^Antiserum was used at a 1:10 dilution. 
^Assay was not done. 
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Table 44. The FAT with H. bovis and DN599 virus 
Virus Globulin type Conjugate Fluorescence 
K22 19S; anti-DN599 Anti-19S 
7S; anti-DN599 Anti-7S 
7S; anti-650 " + 
650 7S; anti-DN599 
7S; anti-650 " + 
DN599 7S; anti-650 
7S; anti-DN599 " + 





Method of plaguing 
The use of specific antiserum in liquid medium to achieve 
plaguing with H. bovis was preferred to using a semi-solid 
agar overlay since it was more convenient, clearer plaques 
were produced, and results were more reproducible. Stevens 
and Groman (258) observed that secondary H. bovis plaques 
developed when this method was used. They attributed this to 
the detachment, translocation, and reattachment of infected 
cells. However, these workers could easily distinguish between 
the primary and the considerably smaller secondary plaques. 
Very few of these small secondary plaques were observed 
in the present study probably because the primary plaques were 
counted within 48 hours post infection. The plaques observed 
by Stevens and Groman (258) took an average of 72 hours to 
develop probably as a result of a higher serum concentration 
(10 per cent) which they used. 
Ten per cent antiserum in plaguing medium resulted in a 
degeneration of the cells which was probably due to antibodies 
directed against cellular antigens. Absorption of antisera 
with EBT cells prior to use markedly reduced this toxicity. 
The presence of antibodies of cellular specificity was not 
unexpected since the partially purified viral antigens used to 
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inoculate rabbits probably still contained some cellular 
antigens, A similar problem exists with H. hominis virus 
since it is extremely difficult to remove cellular anti­
gens from purified antigen preparations of this virus (212). 
However, virus antigens were prepared from infected MDBK 
cells and antisera proved to be toxic to EBT cells as well, 
suggesting that the 2 cell types may share one or more anti­
gens. Such antigen(s) could be genetically determined but 
it has also been established that some cell surface antigens 
may be determined by the antigens in the medium in which the 
cells are grown (81). 
The use of 0.5 per cent specific antiserum in plaguing 
medium resulted in rapid plaque formation by H. bovis (30 to 
48 hours instead of 48 to 72 hours with an agar overlay) and 
at this concentration prior absorption of antiserum with 
cells was not required. The added benefit of storing plaguing 
medium for a considerable period at 4C was especially con­
venient in the neutralization kinetics procedure when large 
numbers of virus samples were assayed. 
Plaque size 
The sizes of plaques produced by the various H. bovis 
strains using plaguing medium containing either anti-650 virus 
or anti-K22 virus serum was determined. There was not a great 
difference in plaque size with most of these viruses but a 
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distinct pattern was observed. The respiratory strains 650 
and 1309 produced the largest plaques in both instances. The 
2 vaccine strains produced similar-sized plaques and the anti­
serum type did not influence the size of plaques produced by 
these 2 viruses. 
One genital strain (K22) produced plaques considerably 
smaller than the other viruses when anti-650 serum was used 
but this difference was not as obvious when anti-K22 serum was 
used. The 2 genital strains produced smaller plaques than any 
of the other strains when anti-650 serum was used but plaques 
due to these viruses were slightly larger than those produced 
by the 2 vaccine strains when anti-K22 serum was used. 
It is difficult to draw any substantial conclusions from 
these results since the variation between strains did not 
seem sufficiently large to warrant further investigation. The 
one genital strain (K22) did produce plaques substantially 
smaller than the rest of the viruses only with the anti-650 
serum, but the other genital strain produced plaques closer in 
size to the vaccine strains. The fact that the respiratory 
strains produced the largest plaques in both trials may be 
significant/ but it would require testing a much larger number 
of isolates to establish the plaque-size parameter as a reli­
able indication of the pathogenicity of a particular strain. 
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Burst size 
Analysis of the average yield per cell of the various H. 
bovis strains in MDBK cells indicated that there was a great 
disparity among the strains. This disparity is illustrated by 
the 304-fold difference in yield between 650 virus and 1309 
virus. However, it was clear that the variation in replica­
tion efficiency of these viruses in MDBK cells was not corre­
lated with the source of origin of the viruses. 
Neutralization kinetics 
The action of complement on the neutralization of H. bovis 
by specific antisera or globulins derived from such antisera 
is similar to what has been reported for H. hominis (86) . It 
was found that early 7S, early 19S, and late 19S globulins 
derived from specific antisera were almost totally complement 
dependent in the neutralization of K. bovis. In conLrast, 
complement only slightly enhanced neutralization by late 7S 
globulins which in the absence of complement neutralized H= 
bovis very efficiently. The dependence of 19S globulins on 
complement in virus neutralization is not surprising since it 
is well established that 19S antibody fixed complement much 
more efficiently than 7S antibody does (94). In addition the 
mechanism of virus neutralization by 19S antibodies may be 
similar to the lysis of erythrocytes by 19S antibodies in the 
complement fixation test (14, 94). Berry and Almeida (14) 
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actually demonstrated holes in the envelopes of infectious 
bronchitis virus neutralized by specific unheated antiserum 
which seems to strengthen this conclusion. 
The true effect of complement in the neutralization of 
viruses is probably not yet fully understood since the in­
fluence of complement in neutralization by early 7S globulin 
has not been explained. In addition other serological pro­
cedures with viruses such as hemagglutination-inhibition with 
influenza virus have also been enhanced by the action of 
complement (211). Several theories on the action of comple­
ment have been proposed. Wallis and Melnick (283) concluded 
that complement enhances virus neutralization by immunoaggre-
gation. These workers suggested that early antibodies were 
monovalent and incapable of aggregating virus without comple­
ment. ThîR theory coincides somewhat with that of Linscott 
and Levinson (136) who proposed that complement functioned by 
contributing bulk in the form of large protein molecules. 
Yoshino and Taniguchi (298) have speculated chat complement 
modifies complement-dependent antibody making the latter more 
accessible to the virus. An alternative theory they proposed 
was that complement binds with the antibody-virus complex 
thereby reinforcing their association. 
It is possible of course that 7S complement-dependent 
antibody functions differently from 19S antibody and that 
complement may play different roles with these 2 antibody types. 
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The possibility that early 7S and 19S antibody may function 
differently in virus neutralization has been demonstrated by 
the observation that anti-gamma globulin enhances 7S neutral­
ization but not 19S neutralization (86). 
The reason for early and late IS antibodies differing 
in their complement dependency is probably a complex function 
of antibody specificity (175), antibody affinity (19, 215), 
antibody valence (19) , and antibody configuration (19). There 
is some evidence to indicate that early 7S antibodies have a 
lower affinity for the antigens involved in serum-virus neu­
tralization (215). Complement then possibly increases the 
affinity of the early 7S antibodies. The specificity of the 
various globulin types derived from specific antisera were 
found to be directed against different H. hominis antigens 
(175). One could thus speculate that the specificity of the 
antibody could influence the complement dependency of such an 
antibody depending on the nature of the antigen or the loca­
tion of the antigen in the virion. An antibody attaching to 
an envelope antigen, for example, would conceivably be more 
likely to damage a virion in the presence of complement if the 
"hole punching" theory of Berry and Almeida (14) holds true. 
The possibility of antigenic determinants controlling 
complement dependency of antibody could also be concluded from 
the immune response in horses to Equine Arteritis virus (EAV). 
Late 7S globulins in immune horses required complement for 
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neutralization of the latter virus (99, 207). This complement 
dependency of the 7S antibodies in their horses is probably 
a characteristic of the EAV antigens since neutralization of 
many other viruses by immune horse sera have not been found 
to be complement dependent. 
Early whole antiserum was also dependent on complement 
in the neutralization of H. bovis. This was expected since 
both early 7S and early 19S antibodies derived from specific 
early antisera were complement dependent. It is not known 
to what extent either of these globulins contributes to the 
neutralization of a virus in the presence of complement. 
The dependence of early antisera on complement for 
virus neutralization has been observed with H. hominis (136, 
296). Such complement-dependent H. hominis antibodies were 
also detectable in sera of patients niiring the period im­
mediately after an anamnestic response (295, 297). The 
evidence obtained in the present study suggests that a similar 
type of immune response occurs with H. bovis. It may thus be 
possible to establish a recent H. bovis infection in a bovine 
herd by the presence of complement-dependent antibodies in the 
sera of the cattle. 
Late immune sera were not dependent on complement for 
neutralization of H. bovis indicating that the 7S globulin 
component of this serum dominates over the 19S component. The 
neutralization rate of H. bovis by late antiserum was slightly 
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enhanced by complement, however, a finding similar to that of 
7S globulin derived from such serum. Others have reported 
similar results with late anti-H. hominis 7S globulins (83, 
254) . In 2 studies complement did not increase late 7S anti-
H. hominis antibody titer even though complement did enhance 
the rate of virus neutralization somewhat (83, 254). Yoshino 
et al. (295) however, reported a 4-fold increase in late IS 
anti-H. hominis globulin titer with complement. 
Preliminary results suggested that H. bovis strains could 
not be differentiated by their neutralization rate using either 
early or late IS antibodies. In contrast, both early and 
late 19S antibodies neutralized the homologous H. bovis strain 
more rapidly than they did a heterologous strain. Late 19S 
antibodies were thus used for comparing H. bovis strains by 
neutralization kinctics since mors late antiserum v;as avail­
able and since the difference in neutralization rate between 
the homologous and heterologous strains seemed greater with 
19S globulins. Hampar et al. (85) reported that late 19S 
antibodies were 4 to 8 times more effective than early 7S, 
late 7S or early 19S antibodies in distinguishing H. hominis 
strains by neutralization kinetics. Similar results were also 
observed when late 19S antibodies were compared with the other 
immunoglobulins in distinguishing strains of simian cyto­
megaloviruses (34) and in differentiating between SA8 herpes­
virus and H. hominis (254) by neutralization kinetics. Thus 
191 
the results with H. bovis appear similar to those with the 
viruses used in this study except that with the former, the 
early 19S antibodies apparently approached the specificity of 
late 19S antibodies. The observation that late 19S antibodies 
have a greater specificity for the homologous strain than early 
19S has, may be associated with antibody affinity. A series 
of immunogen inoculations into an animal, if spaced in time so 
that the response to each dose has declined before the next 
administration, results in the average affinity of the anti­
bodies being greater after each dose (94). Another factor 
which may play a role in the specificity of an antibody type 
is that the different immunoglobulin types may be directed 
against different virion antigens (175). The immunoglobulin 
type representing the antibodies directed against strain 
specific-antiqenic determinants involved in virus neutraliza­
tion, would have greater specificity for the homologous virus 
strain. 
Neutralization kinetics trials of H. bovis strains with 
late 19S antibodies revealed significant differences between 
some of the strains. An unexpected and striking observation 
was the extremely rapid neutralization of the vaccine strains 
with both anti-IPV and anti-IBR sera. Even though the neutral­
ization of the vaccine strains was dramatically faster than any 
of the other H. bovis strains, the former could not be tested 
by the Student T test against the other strains because of 
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their relatively much larger standard error in linear 
regression. This is probably due to the fact that the vaccine 
strains were virtually completely neutralized within 5 minutes. 
An accurate slope for these two strains would have required 
considerably shorter intervals between assays. It is diffi­
cult to explain how heterologous strains could be neutralized 
more rapidly than the homologous strain. Perhaps the answer 
lies in cell adaptation of the vaccine strains which have un­
dergone a virulence modification due to a large number of 
passages in cell culture. These passages may have made virus 
antigens involved in neutralization more accessible to the 
action of antibodies. Herpesviruses may acquire new antigens 
after several passages through cell cultures (82). Cell 
passage does have an effect on the surface charge on H. bovis 
virions (155) which could also influence the specific binding 
of antibodies to antigens on the virion surface. Since the 
original charges on the surface of cell-passaged H. bovis 
virions were restored by passage through cattle (155), these 
neutralization trials should be repeated with the vaccine 
strains after passages through cattle= Such an experiment 
would establish whether the differences observed in the 
neutralization kinetics test with the vaccine strains were 
stable characteristics or not. 
The two vaccine strains could not be distinguished from 
one another by their rates of neutralization with either anti-
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IPV virus or anti-IBR virus 19S globulins. The source and 
attenuation history of these strains is not known, making it 
difficult to evaluate these parameters with respect to the 
results obtained in neutralization kinetics. 
The two respiratory strains K22 and Steiner had similar 
neutralization rates when anti-650 virus 19S antibodies were 
used. The somewhat surprising result with the genital 
strains was that they were neutralized at a significantly 
more rapid rate than the homologous respiratory strain. 
The two respiratory strains had similar neutralization slopes 
with the anti-650 19S globulins. Thus with the latter globu­
lins, 3 significantly different neutralization rates were 
observed, the respiratory strains were neutralized at a slower 
rate than the genital strains which, in turn, were neutralized 
mors slowly than the vaccine strains. Although it is tempting 
to speculate that the differences in neutralization rate be­
tween the respiratory and genital strains may be associated 
with antigens related to their pathogenicity, another factor 
must be considered. In the light of the results observed with 
the vaccine strains the cell passage level of the other strains 
has to be considered since the respiratory strains used were 
freshly isolated strains while the genital strains have been 
maintained in the laboratory for a considerable period. The 
one genital strain (K22) was first isolated in 1958 (120) . 
The question then arises whether the observed neutralization 
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differences are related to stable strain-specific antigens or 
whether they were a function of cell adaptation. The cell pas­
sage level of the vaccine strains is probably considerably high­
er than that of the genital strains, however, and it seems then 
the rate of neutralization of H. bovis strains could be a 
function of their passage level in cells. This question, how­
ever, can only be resolved by either passaging these strains 
in cattle prior to comparison trials or by using strains with 
a similar cell-passage history. 
Almost identical results were obtained when late anti-
K22 19S globulins were used except that Steiner virus had a 
similar neutralization slope to the 2 respiratory strains. 
Since the results with anti-650 198 globulins were so clear 
cut, the test was repeated with Steiner and 650 viruses using 
auLi-K22 193 globulins but the results were similar. Thus 
even though K22-virus was neutralized more rapidly than the 
other 3 nonvaccine strains, these 4 strains could not be 
categorized according to their origin or cell-passage level 
using anti-K22 19S antibodies. 
The reason for the discrepancy observed with the 2 195 
antibody preparations in the relative rate at which Steiner 
virus is neutralized is not clear. This discrepancy may be re­
lated to the relative affinity and/or avidity of the 19S anti­
body preparations and the relative accessibility of the viral 
antigenic determinants involved in neutralization. 
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The distinctive neutralization rate of the vaccine 
strains may have practical applications in differentiation of 
wild and attenuated strains in outbreaks of disease due 
to H. bovis. It is also possible that anti-650 19S globulins 
could be used in the neutralization kinetics test to dis­
tinguish respiratory and genital strains from one another , but 
in the light of the above arguments further work is necessary 
to confirm this. 
Previous work in which strains of H. bovis were compared 
by neutralization kinetics was restricted to the use of whole 
antisera (29, 90). These workers did observe some strain 
differences but were unable to detect consistent patterns in 
their results. Buening and Gratzek (29) also observed that 
some heterologous strains were neutralized more rapidly than 
4- V» 1 rrrM i c c ^  ^  4 v-» n 4- 4- 1 1 3 c? r? n rv ri l<r>TTo"lo r>*F 4-V>o 
strains used were not considered in their study. 
Immunofluorescence 
A greenish autofluorescence of EBT cells interfered with 
the FAT. This problem v.'as virtually eliminated by selecting a 
suitable barrier filter. Although autofluorescence can be 
eliminated by counterstaining procedures (205), the problem 
was first approached by trying different barrier filters since 
it is known that the nature of autofluorescence depends to a 
large extent on the barrier filter used (186). 
196 
Nonspecific fluorescence is more of a problem in the 
indirect FAT than in the direct FAT (186). In this study, 
nonspecific fluorescence was reduced considerably by DEAE 
cellulose chromatography of conjugates, absorption of anti­
body preparations with cells, and by hydrating samples with 
buffer before applying the sera or conjugates. The elimination 
from conjugates of unreacted fluorescein (186), conjugated 
immunoglobulin molecules with a high fluorescein to protein 
ratio (159), and conjugated serum proteins other than 
immunoglobulins (159) by DEAE cellulose chromatography has been 
found to result in an improved specificity in the FAT. Viral 
antisera probably contained a proportion of antibodies directed 
against cellular antigens since cell absorption of antisera 
or globulins derived from such antisera virtually eliminated 
the fluoresGcncc observed with ncninfected cells= 
Virus preparations treated with 19S antibodies 
fluoresced only after the anti-19S conjugate was used sug­
gesting that very little contamination of the 19S preparations 
with 7S antibodies occurred. However, 7S-globulin-treated 
samples fluoresced when either anti-19S or anti-7S globulin 
conjugate was used. These observations suggested that the 
7S globulins shared some antigenic determinants with 19S globu­
lins or that the 7S-globulin preparations used either as an 
immunogen in the preparation of the anti-7S serum or in the 
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FAT were contaminated with 19S globulins. If such contami­
nation occurred, it must have been at levels below that de­
tectable by immunoelectrophoresis or immunodiffusion. 
Fluorescence was observed almost exclusively on the 
surface of infected cells when 19S antibodies were used. This 
suggests that either these antibodies possessed specificity 
directed at antigens present in sufficient quantities only at 
the surface of cells or that these large antibody molecules 
were incapable of penetrating through the cell membranes. 
Herpesviruses have been found to produce virus-specific anti­
gens at the cell surface (101). Other workers observed 
fluorescence within Cytomegalovirus- (236) and H. hominis 
(185)-infected cells with anti-IgM conjugates. However, since 
whole sera were used in the latter experiments there may have 
been a reaction between the 7S and the anti-IqM coniugate as 
was observed in this study with H. bovis. 
The anti-IPV and anti-IBR 19S antibody preparations were 
used for comparing H. bovis strains by the FAT, but no dif­
ferences between the strains were observed. Even after each 
antibody preparation was absorbed with a heterologous virus 
in an attempt to narrow its specificity the virus strains were 
still indistinguishable by the FAT. 
Several workers were able to distinguish H. hominis 
strains by the FAT (129, 185). In these studies the antibody 
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preparations were rendered strain specific by absorption with 
the heterologous strain (129, 185) or by using high dilutions 
of antiserum (185). Neither of these procedures was success­
ful in differentiating between strains of H. bovis. Lucio 
and Hitchner (138) however, distinguished intensely fluorescing 
homologous infectious bronchitis virus from fainter fluorescing 
heterologous strains in the FAT. Since herpesvirus antigens 
produced at cell surfaces are sensitive to acetone (101) per­
haps some strain-specific antigens were destroyed during 
fixation. 
Immunoelectroosmophoresis 
The lEOP test was extremely sensitive in detecting 
Australia antigen (87) , African Swine Fever virus (189), and 
H. hominis antibodies (109). Jeansson (109) used this pro­
cedure to differentiate between the two H. hominis types by 
using cross-absorbed antisera which reacted only with the 
homologous strain in the lEOP test. 
No reaction was observed between H. bovis antigens and 
19S antibodies suggesting that these antibodies were either 
not reactive in the test or insufficient amounts were present. 
Distinct lines of precipitation were observed between H. bovis 
antigens and 7S antibodies. These bands were observed in many 
instances even with the greatest dilution (1:40) of 7S anti­
body. The number of bands observed depended on the particular 
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antibody-antigen combination. Three virus strains (1309, 
Diamond, and Jensal) formed 3 bands with anti-550 7S anti­
bodies but only 2 bands with anti-K22 7S globulins. The 
other 3 strains (K22, Steiner, and 6 50) formed 2 bands with 
anti-650 7S globulins, but only one band resulted with anti-
K22 7S globulins. 
The H. bovis strains can be divided into 2 groups ac­
cording to their reaction in the lEOP test. The two genital 
strains (Steiner and K22) and one respiratory strain (650) 
reacted similarly while the 2 vaccine strains and one respira­
tory strain (1309) were indistinguishable in the test. The 
latter group possessed one detectable antigen more than the 
former group. It is not clear from these results whether this 
is a qualitative or quantitative difference. Absorption of 
virus antigens were tested with such antibodies. In contrast, 
650 virus absorption of anti-K22 7S antibodies resulted in the 
disappearance of only one band when antigens of the vaccine 
strains and 1309 were tested. Bands did not disappear from 
the reaction between K22, Steiner and 650 antigens and K22 7S 
antibodies after absorption. The disappearance of a particular 
precipitin reaction in the lEOP test is probably a complex 
function of the relative amount of antibody to a particular 
antigenic determinant present in the antiserum and the amount 
of this antigen in the absorbing preparation. Since tho number 
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of reactions occurring between an antigen and antibody in the 
lEOP test was also dependent on the antiserum used, the pres­
ence and amount of various antigens in the immunogen probably 
plays an important role. Thus 650 virus elicited anti­
bodies to more antigens than K22 virus did judging from the 
test results. It is interesting to note, however, that tests 
with vaccine strains and 1309 virus antigens produced more 
lines than with the homologous antigens. These results 
are not necessarily incongruous since minor antigens may 
elicit good antibody responses upon repeated inoculations into 
animals (94). Thus, if an antigen constitutes a minor propor­
tion of the antigens in a immunogen, the reaction between 
the minor antigen and specific antibodies may not be de­
tectable by lEOP even though a sufficient quantity of anti­
bodies were present in the resulting sérum. This serum, how­
ever, could conceivably produce a positive reaction when 
tested with another preparation containing a much larger pro­
portion of the antigen in question. 
Radial iimnunodiffusion 
Schild et a^. (234) used a reverse single RID test to 
quantitate influenza virus antibodies in specific anti-
sera. They used gel layers containing purified enveloped in­
fluenza virions and antisera directed against various influenza 
antigens were quantitated by radial diffusion in these gels. 
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This procedure was also used by Cowan and Wagner (41) for the 
detection and quantitation of Foot and Mouth Disease virus 
antibodies. The reverse RID test was unsatisfactory when 
applied to H. bovis since it proved to be relatively insensi­
tive and precipitin zones were difficult to identify in 
gels due to the turbidity created by the incorporation of the 
virus preparations. 
The standard RID test was then adapted for use with H. 
bovis strains by incorporating IS antibodies in agarose gels 
and applying viral antigen in wells prepared in these gels. 
Precipitin rings developed within 24 hours and reached a maxi­
mum size in 3 to 4 days. Multiple rings developed around 
the wells indicating that several antigens were detected by 
this procedure. This result could have been expected since 
the anciyens used probably contained mOst of the structural 
virion proteins as well as soluble proteins associated with 
viral replication. The RID procedure proved to be a sensitive 
method for detecting H. bovis 7S antibody since distinct rings 
of precipitation were observed at the greatest dilution (1:80) 
of antibodies used. The standard RID test was found to be 
quantitative with respect to the antigen since the area of the 
zone of precipitation is directly proportional to the amount 
of antigen placed in the well (144) . Some precipitin rings 
were fainter or not detectable at higher concentrations and 
also at lower concentrations of antibodies in the support gels, 
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suggesting that optimal proportions of antigen and antibody 
are important in this test. Single dilutions of antiserum 
should not be used in this test for viral antigens since some 
precipitin rings may be missed if dilutions are selected so 
that the antigen to antibody proportions are not suitable 
for precipitation. 
The results observed in the RID test with various H. 
bovis strains do not seem to follow a particular pattern. 
Three rings of precipitation were observed with the vaccine 
strains and 1309 virus while only 2 rings were observed with 
the 2 genital strains and 550 virus when anti-K22 7S globulins 
were used. This separates the virus strains into 2 identical 
groups as with the lEOP test. However, one ring remained with 
every strain after absorption of anti-K22 globulins with 1309 
rns . 'Tnrçe pr pri pi r i n rinns resulted with all the VITUS 
strains when anti-640 IS globulins were used. This finding 
is in agreement with the results of the lEOP test in that 
more antigens were detectable with anti-650 globulins than 
with anti-K22 globulins. The 650 virus apparently elicited 
antibodies in a rabbit to an antigen present in all the strains, 
but K22 virus, when inoculated into rabbits, resulted in a much 
poorer response to these antigens. A tolerance phenomenon may 
be responsible for this observation. If the antigens in 
question were present in the K22 virus inoculum in such low 
concentrations a low dose tolerance could occur (94). 
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Absorption of anti-650 7S globulins prior to use in the 
test resulted in the disappearance of one band with all the 
viruses except 650. Thus except for 650 virus the H. bovis 
strains were indistinguishable in the RID test when anti-
650 7S globulins were used. 
Since the RID test is quantitative with respect to the 
antigen, the diameters of the rings produced by the various 
H. bovis strains were compared. These data were difficult to 
evaluate since no particular pattern evolved. The rings with 
the largest diameters were produced with 1309 virus and Jensal 
virus while 650 virus produced the smallest rings when anti-
K22 7S globulins were used. With anti-650 7S globulins, 
Steiner and 1309 viruses produced the largest rings of 
precipitation while 650 and Diamond viruses produced the 
smallest zones. The only real consistent pattern here was that 
one respiratory strain (1309) produced some of the largest 
zones while the other strain (650) produced the smallest zones 
with both antibody preparations. 
It is difficult to make concrete conclusions on differ­
ences between H. bovis strains with the RID and lEOP tests 
since it is difficult to standardize the amount of antigen 
used in these tests. Since these tests were dependent on 
antigen concentrations, the results obtained may only have 
reflected the relative efficiency at which the viruses repli­
cated in MDBK cells. In addition, late 78 antibody was used 
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for these tests and it is known that this antibody type 
has a broader specificity than early antibodies (94). 
However, it has been shown by Schneweiss and Nahmias (237) 
that H. hominis types 1 and 2 possess both shared and strain-
specific antigens which are detectable by immunodiffusion, a 
reaction which is largely dependent on 7S antibody. 
The DN599 Virus Group 
Relationship to K. bovis 
The DN599 virus group was not related to H. bovis by any 
of the biological and serological parameters measured. Pre­
vious work (180, 181, 249) on the relationship of the DN599 
virus group to other herpesviruses has been limited since 
these workers were unable to produce antisera against the DN599 
virus group. Smith et al. (249) suspecbed that DNn99 and FTC 
viruses were related based on their similar effect on cell cul­
tures. Since Mohanty et (180) was unable to neutralize DN599 
virus with antisera to several other herpesviruses, he con­
cluded that the former was unrelated to these viruses. He 
also failed, however, to neutralize DN599 virus with sera of 
rabbits or calves immunized with the homologous virus (180, 
181) which may raise some questions about the validity of the 
conclusions drawn from his serological studies. 
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Propagation and assay 
Considerable difficulty was encountered in the assay of 
DN599, FTCl and Vll viruses. Many different approaches to 
assaying these viruses were attempted but only limited success 
was achieved. Virus assay in cell cultures propagated in tubes 
was discarded early in this study since only very low titers 
-3 -4 (10 to 10 ) were observed and virus growth in the terminal 
dilutions were observed only after 2-3 weeks incubation. 
The plaque assay method proved to be more satisfactory after 
some initial problems with this procedure had been worked out. 
One factor which facilitated both the propagation and 
assay of these viruses was the infection of freshly seeded 
cells. Cells infected in this manner developed a cytopathic 
effect much earlier than cells in a stationary growth phase. 
It would seem that active metabolism of the cells enhanced 
viral replication. Perhaps these viruses require a cellular 
enzyme in their replication that is present in a higher con­
centration in actively replicating cells than in stationary 
cells. The time at which plaques developed was reduced from 
10-12 days post infection to 5-6 days when freshly seeded 
cells were infected. 
Secondary plaques were not observed even when the overlay 
was placed on infected cells 72-96 hours post infection. This 
is consistent with the above observations since any progeny 
virus which may have been produced within the 72-96 hours would 
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have to infect cells which by that time were in the stationary 
phase of growth. Since primary plaques were counted at 6 
days post infection, the secondary plaques would not yet 
have developed. 
Others have found that infection of cells before seeding 
was a valid, sensitive and precise procedure for assaying H. 
hominis (192, 220). They pointed out that this procedure re­
duced technical manipulation, saved on media, and results were 
available sooner. However, the reduction in time referred to 
above was due to elimination of the step of allowing monolayers 
to develop before infection of the cells. The time required 
for plaque development by H. hominis after infection of the 
cells was not reduced significantly by using the above pro­
cedure. 
Protamine supplementation of agar overlays enhanced plaque 
formation by DN599, FTCl, and Vll viruses. Similar results 
were reported by Wallis and Melnick (284) with Adeno, H. hominis 
and Echo viruses. They attributed the protamine enhancement 
of herpesvirus plaques to an enhanced diffusion of the virus 
through the agar due to the positive charge imparted to the 
gel by the protamine. They also suggested that protamine 
neutralizes the inhibitory effects of some cell products and 
enzymes on plaque formation. Plaque formation was not en­
hanced by DEAE dextran which is also in agreement with Wallis 
and Melnick's results with H. hominis (284) . 
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Some investigators reported that secondary overlays 
placed at various intervals after infection on the original 
overlay enhanced herpesvirus plaque formation (43, 227, 289). 
Secondary overlays were used on cells infected with DN599, 
FTCl, andVll, but significant plaque enhancement was not 
observed. 
Since some reports indicated that methyl cellulose (61, 
89, 208) or agarose (132, 284, 289) overlays resulted in im­
proved plaque production by herpesviruses, these overlays were 
compared with an agar overlay using DN599, FTCl, and Vll 
viruses. The results with the former overlays were disappoint­
ing. Plaques produced by these viruses under methyl cellu­
lose were very indistinct while the cells under the agarose 
overlays rapidly degenerated. The reason for the toxic effect 
of the agarose on RhT cells is nncieBr- Tr is nor known 
whether the toxicity was associated with just this particular 
batch of agarose since agarose from other sources was not used. 
This toxic effect on cells by agarose has apparently not been 
reported by investigators who have used it (132, 284, 289). 
The serum type and concentration in overlays have been 
found to influence plaque production by herpesviruses (132). 
Sheep, rabbit and fetal calf serum supplementation in agar over­
lays were compared for their influence on plaque production by 
DN599 virus. Superior plaques in larger numbers were observed 
with the rabbit-serum-supplemented overlay. Thus rabbit serum 
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was routinely used in agar overlays in the assay of DN599, 
FTCl, and Vll viruses. 
Although the technique of using a liquid medium supple­
mented with specific immune serum resulted in satisfactory 
plaque development by H. bovis, distinct plaques did not de­
velop in DN599 virus-infected cells. Plaque formation by a 
virus in the presence of antibody was found to be due to a 
cell to cell spread of the virus since all infective extra­
cellular virus was neutralized (258). It is possible then 
that DN599 virus spreads primarily from cell to cell by first 
releasing the virus extracellularly which then reinfects adja­
cent uninfected cells. 
Serum-virus neutralization studies 
Several unique features characterized neutralization of 
DN599, FTCl, and Vll viruses. A significant observation was 
that specific neutralization of these viruses was extremely 
slow. In a neutralization kinetics experiment carried out 
over 3 hours with a potent antiserum, 14 to 16 per cent of 
infectious virus remained. It is also important to note that 
after one hour of neutralization time only 40 to 50 per cent of 
infectious virus had been neutralized. 
The slow neutralization of DN599 by specific antisera 
may be the reason for the failure of Mohanty to achieve neu­
tralization with sera from animals inoculated with this virus. 
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Considering the observations discussed above, it is possible 
that very little neutralization would be observed if a neu­
tralization time of one hour was allowed and virus assay 
was carried out by the insensitive tube method. 
It was also noted that neutralization of the first 50 
to 60 per cent of these viruses was approximately logarithmic 
after which the rate of neutralization decreased and became 
irregular. The slow and irregular rate of neutralization 
of these viruses by specific immune serum is difficult to 
explain since some of the sera tested had relatively high 
titers (1:80-1:120). 
Since neutralizing antibody does not irreversibly in­
activate viral infectivity (56), it is possible that anti­
bodies of low avidity resulting in some dissociation of virus-
antibody complexes could result in the phenomena observed 
with DN599 virus neutralization. The avidity of an antibody-
antigen complex has been found to depend on the goodness of 
fit (affinity) and on the nearness to which the components can 
approach one another (94) . These 2 factors were found to be 
influenced by the quality of the antigen with respect to its 
ability to induce antibodies with high affinity and the 
accessibility of these antigens to such antibodies (94) . The 
argument that some of the DN599 virus-antibody complexes were 
reversible was strengthened by the observation that frequently 
occasional virus plaques were seen even with low dilutions of 
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high-titer antisera in the neutralization test. Complement 
did not improve the avidity of the virus-antibody reaction 
since it did not enhance neutralization of these viruses by 
immune sera. 
Another possible characteristic of the immune response 
in rabbits to DN599 may be that it is relatively transient. 
This conclusion was arrived at after the observation that serum 
taken from a rabbit 10 days after the last of a series of inoc­
ulations with DN599 virus had a titer of 1:120 while serum taken 
5 weeks later had a titer of 1:5. 
Reciprocal neutralization tests indicated that DN599, 
FTCl, and Vll viruses were serologically indistinguishable. 
One may conclude from this that this virus group is widespread 
in the U.S. since DN599 was isolated in Maryland, FTC from 
Colorado steers, and Vll from an Iowa cow. Hohanfcy et al. (181) 
reported that DN599 produced severe respiratory disease in 
calves while Smith et al. (249) observed a milder respiratory 
condition in FTC-virus infected calves. Vll virus was isolated 
from leukocytes of a cow with lymphosarcoma, and pathogenicity 
studies have not been done with this virus. Mohanty et (180) 
were unable to detect antibodies in the sera of 84 Maryland 
cattle. Since some of the parameters of the neutralization of 
DN599 virus by specific rabbit antisera have been determined in 
this study, the use of immune bovine sera in this test should be 
investigated. Should a serum-virus neutralization test with 
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bovine serum prove to be feasible, a survey for anti-DN599 
virus antibodies in the sera of cattle could be undertaken to 
determine the distribution and significance of this virus. 
The fluorescent antibody test 
Antibody activity against DN599 virus, FTCl, and Vll 
viruses was observed in both 19S and 7S globulin fractions 
of antisera to all 3 viruses. This test confirmed that 
DN599, FTC, and Vll viruses were serologically homogeneous. 
Fluorescence with 19S antibodies was similar to that seen 
with H. bovis since fluorescence was seen mainly at cell mem­
branes. As mentioned above this suggests that either the 19S 
antibodies were unable to penetrate into the cells or the anti­
gens to which the 19S antibodies were directed occurred in 
detectable quantities only at or near the cell surface. 
Fluorescence with 7S antibodies resulted in intense perinuclear, 
granular cytoplasmic and bright cell-surface fluorescence. 
Nuclear fluorescence did not seem to occur. The fluorescence 
observed in DN599 virus-infected cells using 7S antibodies 
was similar to what has been described with H. bovis (13,- 55,-
57, 69, 135, 272). 
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SUMMARY 
Late and early 19S and early 78 rabbit antibodies re­
quired complement to neutralize Herpesvirus bovis. Late 
rabbit 7S antibodies neutralized H. bovis in the absence of 
complement. 
Late 19S rabbit antibodies were used to compare various 
H. bovis strains by neutralization kinetics. Two vaccine 
strains were indistinguishable from one another when either 
anti-IPV or anti-IBR late 19S globulins were used. These 2 
vaccine strains were neutralized far more rapidly than 2 IPV 
and 2 IBR strains using either of the 2 19S globulin prepara­
tions . 
The 2 genital strains were indistinguishable from one 
another but were neutralized significantly more rapidly than 
the 2 respiratory strains when late anti-IBR 19S globulins 
were used. The 2 respiratory strains were indistinguishable 
from one another using the latter globulin preparation. 
Similar results were observed with late anti-IPV 19S globulins 
except that one genital strain was neutralized at a similar 
rate to the respiratory strains. 
A fluorescein isothiocyanate-7S globulin conjugate was 
prepared from chicken anti-rabbit 19S globulin serum. The H. 
bovis strains were indistinguishable in the indirect fluores­
cent antibody test using either the anti-IPV or anti-IBR 
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rabbit 19S globulins and the above conjugate. Absorption of 
19S globulin preparations with cells infected with a hetero­
logous virus strain reduced the intensity of fluorescence of 
preparations of all the virus strains. 
The iiranunoelectroosmophoresis (lEOP) and radial immuno­
diffusion (RID) procedures were adapted for use with H. bovis 
soluble antigens. Late 7S antibodies were used in these 
tests. Late IgM antibodies did not react in the lEOP test. 
Differences were observed between the various H= bovis strains 
but these differences could not be correlated with the origin 
of the viruses. 
Various parameters of plaque production by DN599, FTCl, 
and Vll viruses in embryonic bovine trachea (EBT) cells were 
investigated. Optimum plaque production by these viruses 
occurred when freshly seeded cells were infected and an agar 
overlay with basal Eagle's medium, protamine (100 yg per ml), 
and 10 per cent rabbit serum was used. 
The rate at which DN599, FTCl, and Vll viruses were 
neutralized by specific antiserum was exceptionally slow but 
high antiserum titers were observed. Reciprocal virus 
neutralization and indirect fluorescent antibody tests sug­
gested that DN599, FTCl, and Vll viruses were antigenically re­
lated. Kinetic neutralization tests indicated that the latter 
3 viruses were not serologically related to H. bovis. 
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